{
"data":[{"Human Gene": "MED12", "Mouse Go Name": "NA", "Human Disease Name": "Opitz-Kaveggia syndrome(OKS)|Ohdo syndrome, X-linked(OHDOX)|Lujan-Fryns syndrome(LUJFRYS)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "GAPGPR", "Human UniProtKB Accession": "Q93074", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "A2AGH6-2", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "A2AGH6-2", "Assay Information": [{"GRAVY Score": "-1.12", "CZE Purity": "76.30", "Special Residues": "R+10", "Molecular Weight": "563.3", "AAA Concentration": "56.991000"}, {"GRAVY Score": "-1.12", "CZE Purity": "76.30", "Special Residues": "R+10", "Molecular Weight": "563.3", "AAA Concentration": "56.991000"}], "Gradients": ["NA"], "Transitions": ["NA"], "Unique in protein": "NA", "Peptide Sequence": "GAPGPR", "Concentration Range": ["NA"]}], "Human ProteinName": "Mediator of RNA polymerase II transcription subunit 12", "Human Go Name": "neural tube closure|post-anal tail morphogenesis|Wnt signaling pathway, planar cell polarity pathway|nucleoplasm|vitamin D receptor binding|transcription coactivator activity|intracellular steroid hormone receptor signaling pathway|spinal cord development|positive regulation of transcription, DNA-templated|chromatin binding|transcription coregulator activity|protein domain specific binding|beta-catenin binding|oligodendrocyte development|regulation of transcription by RNA polymerase II|negative regulation of Wnt signaling pathway|membrane|thyroid hormone receptor binding|stem cell population maintenance|heart development|ubiquitin ligase complex|axis elongation involved in somitogenesis|signaling receptor activity|transcription initiation from RNA polymerase II promoter|canonical Wnt signaling pathway|RNA polymerase II distal enhancer sequence-specific DNA binding|protein C-terminus binding|nucleus|embryonic neurocranium morphogenesis|ubiquitin protein ligase activity|positive regulation of transcription by RNA polymerase II|nuclear receptor transcription coactivator activity|mediator complex|embryonic brain development|androgen receptor signaling pathway|endoderm development|Schwann cell development", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "Thyroid hormone signaling pathway", "Biological Matrix Details": [], "Gene": "Med12", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'A2AGH6-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'A2AGH6-2', 'Assay Information': [{'GRAVY Score': '-1.12', 'CZE Purity': '76.30', 'Special Residues': 'R+10', 'Molecular Weight': '563.3', 'AAA Concentration': '56.991000'}, {'GRAVY Score': '-1.12', 'CZE Purity': '76.30', 'Special Residues': 'R+10', 'Molecular Weight': '563.3', 'AAA Concentration': '56.991000'}], 'Gradients': ['NA'], 'Transitions': ['NA'], 'Unique in protein': 'NA', 'Peptide Sequence': 'GAPGPR', 'Concentration Range': ['NA']}", "SubCellular": "NA", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "Mediator of RNA polymerase II transcription subunit 12", "UniProtKB Accession": "A2AGH6-2"}, {"Human Gene": "HSP90AB1", "Mouse Go Name": "cellular response to organic cyclic compound|placenta development|cytosol|regulation of type I interferon-mediated signaling pathway|identical protein binding|negative regulation of proteasomal protein catabolic process|dendritic growth cone|positive regulation of cell size|ion channel binding|regulation of cellular protein localization|HSP90-CDC37 chaperone complex|regulation of interferon-gamma-mediated signaling pathway|cellular response to interleukin-4|axon extension|cellular response to drug|CTP binding|protein-containing complex|positive regulation of protein serine/threonine kinase activity|positive regulation of cell differentiation|positive regulation of phosphoprotein phosphatase activity|tau protein binding|drug binding|positive regulation of transforming growth factor beta receptor signaling pathway|negative regulation of apoptotic process|negative regulation of transforming growth factor beta activation|protein dimerization activity|protein folding|peptide binding|histone deacetylase binding|positive regulation of protein binding|negative regulation of complement-dependent cytotoxicity|negative regulation of protein metabolic process|histone methyltransferase binding|DNA polymerase binding|nucleus|positive regulation of nitric oxide biosynthetic process|UTP binding|protein homodimerization activity|heat shock protein binding|double-stranded RNA binding|apical plasma membrane|positive regulation of cyclin-dependent protein kinase activity|dATP binding|regulation of protein ubiquitination|brush border membrane|kinase binding|axonal growth cone|response to salt stress|positive regulation of protein kinase B signaling|TPR domain binding|positive regulation of telomerase activity|supramolecular fiber organization|response to organic substance|sulfonylurea receptor binding|establishment of cell polarity|neuronal cell body|lysosomal membrane|nitric-oxide synthase regulator activity|aryl hydrocarbon receptor complex|telomerase holoenzyme complex assembly|ATP-dependent protein binding|protein kinase binding|COP9 signalosome|response to cocaine|ooplasm|positive regulation of protein localization to cell surface|sperm head plasma membrane|cytoplasm|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|mitochondrion|cell surface|disordered domain specific binding|melanosome|extracellular region|positive regulation of protein import into nucleus, translocation|negative regulation of cell cycle arrest|ubiquitin protein ligase binding|ATP binding|chaperone-mediated protein complex assembly|unfolded protein binding|basolateral plasma membrane|perinuclear region of cytoplasm|GTP binding|virion attachment to host cell|positive regulation of peptidyl-serine phosphorylation|inclusion body|telomere maintenance via telomerase|negative regulation of neuron apoptotic process|central nervous system neuron axonogenesis", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "LGIHEDSTNR<br>IDIIPNPQER<br>EQVANSAFVER", "Human UniProtKB Accession": "P08238", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:16023 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "P11499", "Assay Information": [{"GRAVY Score": "-1.18", "CZE Purity": "89.36", "Special Residues": "R+10", "Molecular Weight": "1150.55", "AAA Concentration": "75.500000"}, {"GRAVY Score": "-1.18", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1140.55", "AAA Concentration": "NA"}], "Gradients": ["NA", "Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|384.528|9|Positive|y9++|10|5|3|519.7456|380|60742.0,Agilent6490|2|True|384.528|13|Positive|y7++|10|5|3|434.6928|380|34061.0,Agilent6490|3|True|384.528|13|Positive|y6|10|5|3|731.3194|380|14127.0,Agilent6490|4|True|384.528|17|Positive|y4|10|5|3|487.2499|380|10285.0,Agilent6490|5|True|384.528|9|Positive|y8++|10|5|3|491.2348|380|6874.0,Agilent6490|1|False|381.19|9|Positive|y9++|10|5|3|514.74|380|60742.0,Agilent6490|2|False|381.19|13|Positive|y7++|10|5|3|429.69|380|34061.0,Agilent6490|3|False|381.19|13|Positive|y6|10|5|3|721.31|380|14127.0,Agilent6490|4|False|381.19|17|Positive|y4|10|5|3|477.24|380|10285.0,Agilent6490|5|False|381.19|9|Positive|y8++|10|5|3|486.23|380|6874.0"], "Unique in protein": "Yes", "Peptide Sequence": "LGIHEDSTNR", "Concentration Range": ["NA", "16023 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;12276.8 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;72380.28 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:1.84E+00(fmol/\u00b5L plasma)<br/>Mouse Plasma", "UniProtKB Accession": "P11499", "Assay Information": [{"GRAVY Score": "-0.82", "CZE Purity": "100.00", "Special Residues": "R+10", "Molecular Weight": "1203.64", "AAA Concentration": "9.000000"}, {"GRAVY Score": "-0.82", "CZE Purity": "83.06", "Special Residues": "NA", "Molecular Weight": "1193.64", "AAA Concentration": "NA"}, {"GRAVY Score": "-0.82", "CZE Purity": "87.44", "Special Residues": "R+10", "Molecular Weight": "1203.64", "AAA Concentration": "8.700000"}], "Gradients": ["Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4", "NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|602.8322|13|Positive|y6|10|5|2|750.3769|380|190315.0,Agilent6490|2|True|602.8322|17|Positive|b3|10|5|2|342.2023|380|104381.0,Agilent6490|3|True|602.8322|9|Positive|b4|10|5|2|455.2864|380|47616.0,Agilent6490|4|True|602.8322|21|Positive|y6++|10|5|2|375.6921|380|30404.0,Agilent6490|5|True|602.8322|29|Positive|y4|10|5|2|539.2812|380|22056.0,Agilent6490|1|False|597.83|13|Positive|y6|10|5|2|740.37|380|190315.0,Agilent6490|2|False|597.83|17|Positive|b3|10|5|2|342.2023|380|104381.0,Agilent6490|3|False|597.83|9|Positive|b4|10|5|2|455.2864|380|47616.0,Agilent6490|4|False|597.83|21|Positive|y6++|10|5|2|370.69|380|30404.0,Agilent6490|5|False|597.83|29|Positive|y4|10|5|2|529.27|380|22056.0"], "Unique in protein": "Yes", "Peptide Sequence": "IDIIPNPQER", "Concentration Range": ["NA", "1.84E+00(fmol/\u00b5L plasma)|0.89(fmol/\u00b5L plasma)|9.71(fmol/\u00b5L plasma)|122|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.01(fmol/\u00b5L plasma)|10.82(fmol/\u00b5L plasma)|Female;2.51E+00(fmol/\u00b5L plasma)|2.51(fmol/\u00b5L plasma)|2.51(fmol/\u00b5L plasma)|2|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.02(fmol/\u00b5L plasma)|3.89(fmol/\u00b5L plasma)|Female;94454.84 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1.43E+00(fmol/\u00b5L plasma)|0.59(fmol/\u00b5L plasma)|10.01(fmol/\u00b5L plasma)|194|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.01(fmol/\u00b5L plasma)|10.35(fmol/\u00b5L plasma)|Female;40904.42 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;19975.4 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;2.31E+00(fmol/\u00b5L plasma)|1.4(fmol/\u00b5L plasma)|9.66(fmol/\u00b5L plasma)|156|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.02(fmol/\u00b5L plasma)|10.71(fmol/\u00b5L plasma)|Female;1.51E+00(fmol/\u00b5L plasma)|0.84(fmol/\u00b5L plasma)|3.54(fmol/\u00b5L plasma)|188|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.01(fmol/\u00b5L plasma)|3.89(fmol/\u00b5L plasma)|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:0.804 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "P11499", "Assay Information": [{"GRAVY Score": "-0.41", "CZE Purity": "88.49", "Special Residues": "R+10", "Molecular Weight": "1258.61", "AAA Concentration": "8.820000"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|630.3169|17|Positive|y8|10|5|2|903.4558|380|8994.0,Agilent6490|2|True|630.3169|21|Positive|b2|10|5|2|258.1084|380|7769.0,Agilent6490|3|True|630.3169|21|Positive|y7|10|5|2|832.4187|380|6335.0,Agilent6490|4|True|630.3169|17|Positive|y9|10|5|2|1002.5242|380|5595.0,Agilent6490|5|True|630.3169|17|Positive|y6|10|5|2|718.3758|380|5539.0,Agilent6490|1|False|625.31|17|Positive|y8|10|5|2|893.45|380|8994.0,Agilent6490|2|False|625.31|21|Positive|b2|10|5|2|258.1084|380|7769.0,Agilent6490|3|False|625.31|21|Positive|y7|10|5|2|822.41|380|6335.0,Agilent6490|4|False|625.31|17|Positive|y9|10|5|2|992.52|380|5595.0,Agilent6490|5|False|625.31|17|Positive|y6|10|5|2|708.37|380|5539.0"], "Unique in protein": "Yes", "Peptide Sequence": "EQVANSAFVER", "Concentration Range": ["0.804 (fmol/\u00b5g Lung)|NA|NA|3|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;0.324 (fmol/\u00b5g Heart)|NA|NA|3|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1.509 (fmol/\u00b5g Brain)|NA|NA|3|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}], "Human ProteinName": "Heat shock protein HSP 90-beta", "Human Go Name": "cellular response to organic cyclic compound|placenta development|cytosol|regulation of type I interferon-mediated signaling pathway|identical protein binding|positive regulation of tau-protein kinase activity|response to unfolded protein|negative regulation of proteasomal protein catabolic process|dendritic growth cone|positive regulation of cell size|ion channel binding|regulation of cellular protein localization|HSP90-CDC37 chaperone complex|neutrophil degranulation|regulation of interferon-gamma-mediated signaling pathway|cellular response to interleukin-4|axon extension|ATPase activity, coupled|cellular response to drug|CTP binding|positive regulation of protein serine/threonine kinase activity|nucleoplasm|RNA binding|positive regulation of cell differentiation|regulation of cellular response to heat|MHC class II protein complex binding|positive regulation of phosphoprotein phosphatase activity|tau protein binding|positive regulation of transforming growth factor beta receptor signaling pathway|negative regulation of transforming growth factor beta activation|protein dimerization activity|protein folding|membrane|Fc-gamma receptor signaling pathway involved in phagocytosis|peptide binding|histone deacetylase binding|protein kinase regulator activity|positive regulation of protein binding|negative regulation of complement-dependent cytotoxicity|negative regulation of protein metabolic process|histone methyltransferase binding|extracellular exosome|DNA polymerase binding|nucleus|positive regulation of nitric oxide biosynthetic process|UTP binding|protein homodimerization activity|heat shock protein binding|double-stranded RNA binding|apical plasma membrane|positive regulation of cyclin-dependent protein kinase activity|dATP binding|regulation of protein ubiquitination|brush border membrane|kinase binding|axonal growth cone|ficolin-1-rich granule lumen|response to salt stress|positive regulation of protein kinase B signaling|TPR domain binding|protein stabilization|positive regulation of telomerase activity|supramolecular fiber organization|cadherin binding|sulfonylurea receptor binding|establishment of cell polarity|neuronal cell body|lysosomal membrane|nitric-oxide synthase regulator activity|secretory granule lumen|aryl hydrocarbon receptor complex|telomerase holoenzyme complex assembly|protein-containing complex|protein kinase binding|ATP-dependent protein binding|response to cocaine|ooplasm|positive regulation of protein localization to cell surface|sperm head plasma membrane|cytoplasm|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|mitochondrion|cell surface|disordered domain specific binding|melanosome|extracellular region|positive regulation of protein import into nucleus, translocation|negative regulation of cell cycle arrest|ubiquitin protein ligase binding|ATP binding|chaperone-mediated protein complex assembly|unfolded protein binding|negative regulation of neuron apoptotic process|perinuclear region of cytoplasm|GTP binding|virion attachment to host cell|positive regulation of peptidyl-serine phosphorylation|xenobiotic metabolic process|inclusion body|telomere maintenance via telomerase|basolateral plasma membrane|central nervous system neuron axonogenesis", "Human Drug Bank": "<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB05134\">CNF1010</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB02424\">Geldanamycin</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB03758\">Radicicol</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB06070\">SNX-5422</a>", "Biological Matrix": "Mouse Brain<br/>Mouse Lung<br/>Mouse Heart", "Human Kegg Pathway Name": "NOD-like receptor signaling pathway|Prostate cancer|Fluid shear stress and atherosclerosis|Estrogen signaling pathway|Antigen processing and presentation|PI3K-Akt signaling pathway|IL-17 signaling pathway|Necroptosis|Th17 cell differentiation|Protein processing in endoplasmic reticulum|Pathways in cancer|Progesterone-mediated oocyte maturation", "Biological Matrix Details": [["16023 (fmol/\u00b5g Lung)", "Female", "LGIHEDSTNR", "P11499", "Mouse Lung"], ["1.84E+00(fmol/\u00b5L plasma)", "Female", "IDIIPNPQER", "P11499", "Mouse Plasma"], ["2.51E+00(fmol/\u00b5L plasma)", "Female", "IDIIPNPQER", "P11499", "Mouse Plasma"], ["94454.84 (fmol/\u00b5g Brain)", "Female", "IDIIPNPQER", "P11499", "Mouse Brain"], ["1.43E+00(fmol/\u00b5L plasma)", "Female", "IDIIPNPQER", "P11499", "Mouse Plasma"], ["19975.4 (fmol/\u00b5g Heart)", "Female", "IDIIPNPQER", "P11499", "Mouse Heart"], ["2.31E+00(fmol/\u00b5L plasma)", "Female", "IDIIPNPQER", "P11499", "Mouse Plasma"], ["1.51E+00(fmol/\u00b5L plasma)", "Female", "IDIIPNPQER", "P11499", "Mouse Plasma"], ["0.804 (fmol/\u00b5g Lung)", "Female", "EQVANSAFVER", "P11499", "Mouse Lung"], ["0.324 (fmol/\u00b5g Heart)", "Female", "EQVANSAFVER", "P11499", "Mouse Heart"], ["1.509 (fmol/\u00b5g Brain)", "Female", "EQVANSAFVER", "P11499", "Mouse Brain"]], "Gene": "Hsp90ab1", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:16023 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'P11499', 'Assay Information': [{'GRAVY Score': '-1.18', 'CZE Purity': '89.36', 'Special Residues': 'R+10', 'Molecular Weight': '1150.55', 'AAA Concentration': '75.500000'}, {'GRAVY Score': '-1.18', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1140.55', 'AAA Concentration': 'NA'}], 'Gradients': ['NA', 'Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|384.528|9|Positive|y9++|10|5|3|519.7456|380|60742.0,Agilent6490|2|True|384.528|13|Positive|y7++|10|5|3|434.6928|380|34061.0,Agilent6490|3|True|384.528|13|Positive|y6|10|5|3|731.3194|380|14127.0,Agilent6490|4|True|384.528|17|Positive|y4|10|5|3|487.2499|380|10285.0,Agilent6490|5|True|384.528|9|Positive|y8++|10|5|3|491.2348|380|6874.0,Agilent6490|1|False|381.19|9|Positive|y9++|10|5|3|514.74|380|60742.0,Agilent6490|2|False|381.19|13|Positive|y7++|10|5|3|429.69|380|34061.0,Agilent6490|3|False|381.19|13|Positive|y6|10|5|3|721.31|380|14127.0,Agilent6490|4|False|381.19|17|Positive|y4|10|5|3|477.24|380|10285.0,Agilent6490|5|False|381.19|9|Positive|y8++|10|5|3|486.23|380|6874.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'LGIHEDSTNR', 'Concentration Range': ['NA', '16023 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;12276.8 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;72380.28 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:1.84E+00(fmol/\\xc2\\xb5L plasma)<br/>Mouse Plasma', 'UniProtKB Accession': 'P11499', 'Assay Information': [{'GRAVY Score': '-0.82', 'CZE Purity': '100.00', 'Special Residues': 'R+10', 'Molecular Weight': '1203.64', 'AAA Concentration': '9.000000'}, {'GRAVY Score': '-0.82', 'CZE Purity': '83.06', 'Special Residues': 'NA', 'Molecular Weight': '1193.64', 'AAA Concentration': 'NA'}, {'GRAVY Score': '-0.82', 'CZE Purity': '87.44', 'Special Residues': 'R+10', 'Molecular Weight': '1203.64', 'AAA Concentration': '8.700000'}], 'Gradients': ['Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4', 'NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|602.8322|13|Positive|y6|10|5|2|750.3769|380|190315.0,Agilent6490|2|True|602.8322|17|Positive|b3|10|5|2|342.2023|380|104381.0,Agilent6490|3|True|602.8322|9|Positive|b4|10|5|2|455.2864|380|47616.0,Agilent6490|4|True|602.8322|21|Positive|y6++|10|5|2|375.6921|380|30404.0,Agilent6490|5|True|602.8322|29|Positive|y4|10|5|2|539.2812|380|22056.0,Agilent6490|1|False|597.83|13|Positive|y6|10|5|2|740.37|380|190315.0,Agilent6490|2|False|597.83|17|Positive|b3|10|5|2|342.2023|380|104381.0,Agilent6490|3|False|597.83|9|Positive|b4|10|5|2|455.2864|380|47616.0,Agilent6490|4|False|597.83|21|Positive|y6++|10|5|2|370.69|380|30404.0,Agilent6490|5|False|597.83|29|Positive|y4|10|5|2|529.27|380|22056.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'IDIIPNPQER', 'Concentration Range': ['NA', '1.84E+00(fmol/\\xc2\\xb5L plasma)|0.89(fmol/\\xc2\\xb5L plasma)|9.71(fmol/\\xc2\\xb5L plasma)|122|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.01(fmol/\\xc2\\xb5L plasma)|10.82(fmol/\\xc2\\xb5L plasma)|Female;2.51E+00(fmol/\\xc2\\xb5L plasma)|2.51(fmol/\\xc2\\xb5L plasma)|2.51(fmol/\\xc2\\xb5L plasma)|2|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.02(fmol/\\xc2\\xb5L plasma)|3.89(fmol/\\xc2\\xb5L plasma)|Female;94454.84 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1.43E+00(fmol/\\xc2\\xb5L plasma)|0.59(fmol/\\xc2\\xb5L plasma)|10.01(fmol/\\xc2\\xb5L plasma)|194|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.01(fmol/\\xc2\\xb5L plasma)|10.35(fmol/\\xc2\\xb5L plasma)|Female;40904.42 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;19975.4 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;2.31E+00(fmol/\\xc2\\xb5L plasma)|1.4(fmol/\\xc2\\xb5L plasma)|9.66(fmol/\\xc2\\xb5L plasma)|156|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.02(fmol/\\xc2\\xb5L plasma)|10.71(fmol/\\xc2\\xb5L plasma)|Female;1.51E+00(fmol/\\xc2\\xb5L plasma)|0.84(fmol/\\xc2\\xb5L plasma)|3.54(fmol/\\xc2\\xb5L plasma)|188|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.01(fmol/\\xc2\\xb5L plasma)|3.89(fmol/\\xc2\\xb5L plasma)|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:0.804 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'P11499', 'Assay Information': [{'GRAVY Score': '-0.41', 'CZE Purity': '88.49', 'Special Residues': 'R+10', 'Molecular Weight': '1258.61', 'AAA Concentration': '8.820000'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|630.3169|17|Positive|y8|10|5|2|903.4558|380|8994.0,Agilent6490|2|True|630.3169|21|Positive|b2|10|5|2|258.1084|380|7769.0,Agilent6490|3|True|630.3169|21|Positive|y7|10|5|2|832.4187|380|6335.0,Agilent6490|4|True|630.3169|17|Positive|y9|10|5|2|1002.5242|380|5595.0,Agilent6490|5|True|630.3169|17|Positive|y6|10|5|2|718.3758|380|5539.0,Agilent6490|1|False|625.31|17|Positive|y8|10|5|2|893.45|380|8994.0,Agilent6490|2|False|625.31|21|Positive|b2|10|5|2|258.1084|380|7769.0,Agilent6490|3|False|625.31|21|Positive|y7|10|5|2|822.41|380|6335.0,Agilent6490|4|False|625.31|17|Positive|y9|10|5|2|992.52|380|5595.0,Agilent6490|5|False|625.31|17|Positive|y6|10|5|2|708.37|380|5539.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'EQVANSAFVER', 'Concentration Range': ['0.804 (fmol/\\xc2\\xb5g Lung)|NA|NA|3|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;0.324 (fmol/\\xc2\\xb5g Heart)|NA|NA|3|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1.509 (fmol/\\xc2\\xb5g Brain)|NA|NA|3|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']}", "SubCellular": "Cytoplasm|Nucleus|Melanosome|Cell membrane|Secreted", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NOD-like receptor signaling pathway|Prostate cancer|Fluid shear stress and atherosclerosis|Estrogen signaling pathway|Antigen processing and presentation|PI3K-Akt signaling pathway|IL-17 signaling pathway|Necroptosis|Th17 cell differentiation|Protein processing in endoplasmic reticulum|Pathways in cancer|Progesterone-mediated oocyte maturation", "Protein": "Heat shock protein HSP 90-beta", "UniProtKB Accession": "P11499"}, {"Human Gene": "PFN1", "Mouse Go Name": "Schaffer collateral - CA1 synapse|neuron projection|cytosol|cytoplasm|modification of postsynaptic actin cytoskeleton|cell cortex|sequestering of actin monomers|positive regulation of DNA metabolic process|adenyl-nucleotide exchange factor activity|cytoskeleton|synapse maturation|regulation of actin filament polymerization|negative regulation of actin filament polymerization|extracellular space|positive regulation of actin filament polymerization|extracellular region|positive regulation of ruffle assembly|actin monomer binding|positive regulation of stress fiber assembly|regulation of transcription by RNA polymerase II|neural tube closure|protein stabilization|actin cytoskeleton organization|phosphatidylinositol-4,5-bisphosphate binding|negative regulation of stress fiber assembly|proline-rich region binding|positive regulation of epithelial cell migration|positive regulation of actin filament bundle assembly|nucleus|Rho GTPase binding|glutamatergic synapse|synapse|positive regulation of transcription by RNA polymerase II|presynapse|actin binding|postsynapse|regulation of actin polymerization or depolymerization|negative regulation of actin filament bundle assembly|positive regulation of ATPase activity|positive regulation of viral transcription|signaling receptor binding|parallel fiber to Purkinje cell synapse|cellular response to growth factor stimulus", "Human Disease Name": "Amyotrophic lateral sclerosis 18(ALS18)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "SSFFVNGLTLGGQK<br>EGVHGGLINK", "Human UniProtKB Accession": "P07737", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P62962", "Assay Information": [{"GRAVY Score": "0.21", "CZE Purity": "91.91", "Special Residues": "K+8", "Molecular Weight": "1461.76", "AAA Concentration": "8.480000"}, {"GRAVY Score": "0.21", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1453.76", "AAA Concentration": "NA"}, {"GRAVY Score": "0.21", "CZE Purity": "83.08", "Special Residues": "K+8", "Molecular Weight": "1461.76", "AAA Concentration": "10.100000"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|731.8932|17|Positive|y9|10|5|2|895.5087|380|79552.0,Agilent6490|2|True|731.8932|21|Positive|y8|10|5|2|781.4658|380|30125.0,Agilent6490|3|True|731.8932|25|Positive|y6|10|5|2|611.3603|380|28495.0,Agilent6490|4|True|731.8932|25|Positive|y10|10|5|2|994.5771|380|28421.0,Agilent6490|5|True|731.8932|21|Positive|b4|10|5|2|469.2082|380|24458.0,Agilent6490|1|False|727.8932|17|Positive|y9|10|5|2|887.5087|380|79552.0,Agilent6490|2|False|727.8932|21|Positive|y8|10|5|2|773.4658|380|30125.0,Agilent6490|3|False|727.8932|25|Positive|y6|10|5|2|603.3603|380|28495.0,Agilent6490|4|False|727.8932|25|Positive|y10|10|5|2|986.5771|380|28421.0,Agilent6490|5|False|727.8932|21|Positive|b4|10|5|2|469.2082|380|24458.0"], "Unique in protein": "Yes", "Peptide Sequence": "SSFFVNGLTLGGQK", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:14268.825 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "P62962", "Assay Information": [{"GRAVY Score": "-0.28", "CZE Purity": "70.89", "Special Residues": "K+8", "Molecular Weight": "1030.55", "AAA Concentration": "NA"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 3,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|1.5|0.4, 1.50|6.3|0.4, 16.00|13.5|0.4, 18.00|13.77|0.4, 33.00|22.5|0.4, 38.00|40.5|0.4, 39.00|81|0.4, 42.90|81|0.4, 43.00|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|516.2904|17|Positive|y7++|10|5|2|373.7236|380|113655.0,Agilent6490|2|True|516.2904|21|Positive|y2|10|5|2|269.1699|380|65706.0,Agilent6490|3|True|516.2904|21|Positive|y6|10|5|2|609.381|380|36049.0,Agilent6490|4|True|516.2904|17|Positive|y7|10|5|2|746.4399|380|34450.0,Agilent6490|5|True|516.2904|17|Positive|y8++|10|5|2|423.2578|380|32896.0,Agilent6490|1|False|512.2904|17|Positive|y7++|10|5|2|369.7236|380|113655.0,Agilent6490|2|False|512.2904|21|Positive|y2|10|5|2|261.1699|380|65706.0,Agilent6490|3|False|512.2904|21|Positive|y6|10|5|2|601.381|380|36049.0,Agilent6490|4|False|512.2904|17|Positive|y7|10|5|2|738.4399|380|34450.0,Agilent6490|5|False|512.2904|17|Positive|y8++|10|5|2|419.2578|380|32896.0"], "Unique in protein": "Yes", "Peptide Sequence": "EGVHGGLINK", "Concentration Range": ["14268.825 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;4986.95 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;6546.175 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}], "Human ProteinName": "Profilin-1", "Human Go Name": "neural tube closure|Wnt signaling pathway, planar cell polarity pathway|cytosol|blood microparticle|modification of postsynaptic actin cytoskeleton|cell cortex|RNA binding|adenyl-nucleotide exchange factor activity|cytoskeleton|regulation of actin filament polymerization|negative regulation of actin filament polymerization|phosphatidylinositol-4,5-bisphosphate binding|positive regulation of actin filament polymerization|positive regulation of ATPase activity|positive regulation of ruffle assembly|actin monomer binding|focal adhesion|regulation of transcription by RNA polymerase II|membrane|protein stabilization|actin cytoskeleton organization|negative regulation of stress fiber assembly|proline-rich region binding|cadherin binding|positive regulation of epithelial cell migration|positive regulation of actin filament bundle assembly|nucleus|Rho GTPase binding|extracellular exosome|glutamatergic synapse|actin binding|negative regulation of actin filament bundle assembly|synapse maturation|cytoplasm", "Human Drug Bank": "<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB07908\">7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN</a>", "Biological Matrix": "Mouse Brain<br/>Mouse Lung<br/>Mouse Heart", "Human Kegg Pathway Name": "Regulation of actin cytoskeleton|Rap1 signaling pathway|Salmonella infection|Shigellosis", "Biological Matrix Details": [["14268.825 (fmol/\u00b5g Lung)", "Female", "EGVHGGLINK", "P62962", "Mouse Lung"]], "Gene": "Pfn1", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P62962', 'Assay Information': [{'GRAVY Score': '0.21', 'CZE Purity': '91.91', 'Special Residues': 'K+8', 'Molecular Weight': '1461.76', 'AAA Concentration': '8.480000'}, {'GRAVY Score': '0.21', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1453.76', 'AAA Concentration': 'NA'}, {'GRAVY Score': '0.21', 'CZE Purity': '83.08', 'Special Residues': 'K+8', 'Molecular Weight': '1461.76', 'AAA Concentration': '10.100000'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|731.8932|17|Positive|y9|10|5|2|895.5087|380|79552.0,Agilent6490|2|True|731.8932|21|Positive|y8|10|5|2|781.4658|380|30125.0,Agilent6490|3|True|731.8932|25|Positive|y6|10|5|2|611.3603|380|28495.0,Agilent6490|4|True|731.8932|25|Positive|y10|10|5|2|994.5771|380|28421.0,Agilent6490|5|True|731.8932|21|Positive|b4|10|5|2|469.2082|380|24458.0,Agilent6490|1|False|727.8932|17|Positive|y9|10|5|2|887.5087|380|79552.0,Agilent6490|2|False|727.8932|21|Positive|y8|10|5|2|773.4658|380|30125.0,Agilent6490|3|False|727.8932|25|Positive|y6|10|5|2|603.3603|380|28495.0,Agilent6490|4|False|727.8932|25|Positive|y10|10|5|2|986.5771|380|28421.0,Agilent6490|5|False|727.8932|21|Positive|b4|10|5|2|469.2082|380|24458.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'SSFFVNGLTLGGQK', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:14268.825 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'P62962', 'Assay Information': [{'GRAVY Score': '-0.28', 'CZE Purity': '70.89', 'Special Residues': 'K+8', 'Molecular Weight': '1030.55', 'AAA Concentration': 'NA'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 3,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|1.5|0.4, 1.50|6.3|0.4, 16.00|13.5|0.4, 18.00|13.77|0.4, 33.00|22.5|0.4, 38.00|40.5|0.4, 39.00|81|0.4, 42.90|81|0.4, 43.00|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|516.2904|17|Positive|y7++|10|5|2|373.7236|380|113655.0,Agilent6490|2|True|516.2904|21|Positive|y2|10|5|2|269.1699|380|65706.0,Agilent6490|3|True|516.2904|21|Positive|y6|10|5|2|609.381|380|36049.0,Agilent6490|4|True|516.2904|17|Positive|y7|10|5|2|746.4399|380|34450.0,Agilent6490|5|True|516.2904|17|Positive|y8++|10|5|2|423.2578|380|32896.0,Agilent6490|1|False|512.2904|17|Positive|y7++|10|5|2|369.7236|380|113655.0,Agilent6490|2|False|512.2904|21|Positive|y2|10|5|2|261.1699|380|65706.0,Agilent6490|3|False|512.2904|21|Positive|y6|10|5|2|601.381|380|36049.0,Agilent6490|4|False|512.2904|17|Positive|y7|10|5|2|738.4399|380|34450.0,Agilent6490|5|False|512.2904|17|Positive|y8++|10|5|2|419.2578|380|32896.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'EGVHGGLINK', 'Concentration Range': ['14268.825 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;4986.95 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;6546.175 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']}", "SubCellular": "Cytoplasm", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Regulation of actin cytoskeleton|Rap1 signaling pathway|Salmonella infection", "Protein": "Profilin-1", "UniProtKB Accession": "P62962"}, {"Human Gene": "EEF2", "Mouse Go Name": "cytosol|cytoplasm|response to hydrogen peroxide|glial cell proliferation|plasma membrane|cellular response to brain-derived neurotrophic factor stimulus|aging|response to ischemia|skeletal muscle contraction|hematopoietic progenitor cell differentiation|response to ethanol|RNA binding|p53 binding|response to endoplasmic reticulum stress|actin filament binding|translational elongation|positive regulation of cytoplasmic translation|response to folic acid|polysome|GTP binding|positive regulation of translation|membrane raft|protein kinase binding|synapse|5S rRNA binding|ribonucleoprotein complex|aggresome|skeletal muscle cell differentiation|GTPase activity|polysomal ribosome|response to estradiol|ribosome binding|translation elongation factor activity", "Human Disease Name": "Spinocerebellar ataxia 26(SCA26)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "AGIIASAR<br>STAISLFYELSENDLNFIK<br>GVQYLNEIK<br>YEWDVAEAR", "Human UniProtKB Accession": "P13639", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P58252", "Assay Information": [{"GRAVY Score": "-0.40", "CZE Purity": "100.00", "Special Residues": "K+8", "Molecular Weight": "1070.57", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|536.3004|17|Positive|y6|10|5|2|787.444|380|39821.0,Agilent6490|2|True|536.3004|13|Positive|b3|10|5|2|285.1557|380|26582.0,Agilent6490|3|True|536.3004|13|Positive|y7|10|5|2|915.5026|380|25589.0,Agilent6490|4|True|536.3004|17|Positive|y4|10|5|2|511.2966|380|18479.0,Agilent6490|5|True|536.3004|13|Positive|y5|10|5|2|624.3807|380|13786.0,Agilent6490|1|False|532.3004|17|Positive|y6|10|5|2|779.444|380|39821.0,Agilent6490|2|False|532.3004|13|Positive|b3|10|5|2|285.1557|380|26582.0,Agilent6490|3|False|532.3004|13|Positive|y7|10|5|2|907.5026|380|25589.0,Agilent6490|4|False|532.3004|17|Positive|y4|10|5|2|503.2966|380|18479.0,Agilent6490|5|False|532.3004|13|Positive|y5|10|5|2|616.3807|380|13786.0"], "Unique in protein": "Yes", "Peptide Sequence": "GVQYLNEIK", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P58252", "Assay Information": [{"GRAVY Score": "0.11", "CZE Purity": "39.91", "Special Residues": "K+8", "Molecular Weight": "2211.1", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|738.0475|41|Positive|y5+++|10|5|3|214.807|380|3133.0,Agilent6490|2|True|738.0475|21|Positive|y9|10|5|3|1087.551|380|1925.0,Agilent6490|3|True|738.0475|13|Positive|y17++|10|5|3|1012.527|380|1699.0,Agilent6490|4|True|738.0475|17|Positive|y7|10|5|3|871.4763|380|1387.0,Agilent6490|5|True|738.0475|9|Positive|b18++|10|5|3|1029.5069|380|1380.0,Agilent6490|1|False|735.3761|41|Positive|y5+++|10|5|3|212.1403|380|3133.0,Agilent6490|2|False|735.3761|21|Positive|y9|10|5|3|1079.551|380|1925.0,Agilent6490|3|False|735.3761|13|Positive|y17++|10|5|3|1008.527|380|1699.0,Agilent6490|4|False|735.3761|17|Positive|y7|10|5|3|863.4763|380|1387.0,Agilent6490|5|False|735.3761|9|Positive|b18++|10|5|3|1029.5069|380|1380.0"], "Unique in protein": "Yes", "Peptide Sequence": "STAISLFYELSENDLNFIK", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:19564.24 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "P58252", "Assay Information": [{"GRAVY Score": "-1.04", "CZE Purity": "100.00", "Special Residues": "R+10", "Molecular Weight": "1147.51", "AAA Concentration": "8.000000"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|574.7665|13|Positive|y7|10|5|2|856.4187|380|45936.0,Agilent6490|2|True|574.7665|13|Positive|b2|10|5|2|293.1132|380|31198.0,Agilent6490|3|True|574.7665|13|Positive|y6|10|5|2|670.3394|380|21053.0,Agilent6490|4|True|574.7665|21|Positive|y5|10|5|2|555.3125|380|20475.0,Agilent6490|5|True|574.7665|29|Positive|y2|10|5|2|256.1643|380|18099.0,Agilent6490|1|False|569.762|13|Positive|y7|10|5|2|846.41|380|45936.0,Agilent6490|2|False|569.762|13|Positive|b2|10|5|2|293.1132|380|31198.0,Agilent6490|3|False|569.762|13|Positive|y6|10|5|2|660.33|380|21053.0,Agilent6490|4|False|569.762|21|Positive|y5|10|5|2|545.3|380|20475.0,Agilent6490|5|False|569.762|29|Positive|y2|10|5|2|246.16|380|18099.0"], "Unique in protein": "Yes", "Peptide Sequence": "YEWDVAEAR", "Concentration Range": ["19564.24 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;12806.84 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;17661.84 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P58252", "Assay Information": [{"GRAVY Score": "1.09", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "757.44", "AAA Concentration": "NA"}, {"GRAVY Score": "1.09", "CZE Purity": "87.71", "Special Residues": "R+10", "Molecular Weight": "767.44", "AAA Concentration": "9.160000"}, {"GRAVY Score": "1.09", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "757.44", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|384.7343|5|Positive|b3|10|5|2|242.1499|380|311984.0,Agilent6490|2|True|384.7343|9|Positive|y5|10|5|2|527.3175|380|103667.0,Agilent6490|3|True|384.7343|9|Positive|y4|10|5|2|414.2335|380|93345.0,Agilent6490|4|True|384.7343|9|Positive|y3|10|5|2|343.1964|380|24565.0,Agilent6490|5|True|384.7343|5|Positive|y6++|10|5|2|320.7044|380|22245.0,Agilent6490|1|False|379.7343|5|Positive|b3|10|5|2|242.1499|380|311984.0,Agilent6490|2|False|379.7343|9|Positive|y5|10|5|2|517.3175|380|103667.0,Agilent6490|3|False|379.7343|9|Positive|y4|10|5|2|404.2335|380|93345.0,Agilent6490|4|False|379.7343|9|Positive|y3|10|5|2|333.1964|380|24565.0,Agilent6490|5|False|379.7343|5|Positive|y6++|10|5|2|315.7044|380|22245.0"], "Unique in protein": "Yes", "Peptide Sequence": "AGIIASAR", "Concentration Range": ["NA"]}], "Human ProteinName": "Elongation factor 2", "Human Go Name": "ribonucleoprotein complex|cytosol|cytoplasm|RNA binding|glial cell proliferation|response to ethanol|cellular response to brain-derived neurotrophic factor stimulus|aging|response to ischemia|ficolin-1-rich granule lumen|extracellular region|skeletal muscle contraction|aggresome|hematopoietic progenitor cell differentiation|plasma membrane|membrane|p53 binding|response to endoplasmic reticulum stress|actin filament binding|translational elongation|cadherin binding|skeletal muscle cell differentiation|polysomal ribosome|nucleus|neutrophil degranulation|secretory granule lumen|GTP binding|positive regulation of translation|membrane raft|extracellular exosome|synapse|5S rRNA binding|response to folic acid|positive regulation of cytoplasmic translation|protein kinase binding|GTPase activity|response to hydrogen peroxide|response to estradiol|ribosome binding|translation elongation factor activity", "Human Drug Bank": "<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB04315\">Guanosine-5'-Diphosphate</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB02059\">Adenosine-5-Diphosphoribose</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB03223\">Diphthamide</a>", "Biological Matrix": "Mouse Brain<br/>Mouse Lung<br/>Mouse Heart", "Human Kegg Pathway Name": "AMPK signaling pathway|Oxytocin signaling pathway", "Biological Matrix Details": [["19564.24 (fmol/\u00b5g Lung)", "Female", "YEWDVAEAR", "P58252", "Mouse Lung"]], "Gene": "Eef2", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P58252', 'Assay Information': [{'GRAVY Score': '-0.40', 'CZE Purity': '100.00', 'Special Residues': 'K+8', 'Molecular Weight': '1070.57', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|536.3004|17|Positive|y6|10|5|2|787.444|380|39821.0,Agilent6490|2|True|536.3004|13|Positive|b3|10|5|2|285.1557|380|26582.0,Agilent6490|3|True|536.3004|13|Positive|y7|10|5|2|915.5026|380|25589.0,Agilent6490|4|True|536.3004|17|Positive|y4|10|5|2|511.2966|380|18479.0,Agilent6490|5|True|536.3004|13|Positive|y5|10|5|2|624.3807|380|13786.0,Agilent6490|1|False|532.3004|17|Positive|y6|10|5|2|779.444|380|39821.0,Agilent6490|2|False|532.3004|13|Positive|b3|10|5|2|285.1557|380|26582.0,Agilent6490|3|False|532.3004|13|Positive|y7|10|5|2|907.5026|380|25589.0,Agilent6490|4|False|532.3004|17|Positive|y4|10|5|2|503.2966|380|18479.0,Agilent6490|5|False|532.3004|13|Positive|y5|10|5|2|616.3807|380|13786.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'GVQYLNEIK', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P58252', 'Assay Information': [{'GRAVY Score': '0.11', 'CZE Purity': '39.91', 'Special Residues': 'K+8', 'Molecular Weight': '2211.1', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|738.0475|41|Positive|y5+++|10|5|3|214.807|380|3133.0,Agilent6490|2|True|738.0475|21|Positive|y9|10|5|3|1087.551|380|1925.0,Agilent6490|3|True|738.0475|13|Positive|y17++|10|5|3|1012.527|380|1699.0,Agilent6490|4|True|738.0475|17|Positive|y7|10|5|3|871.4763|380|1387.0,Agilent6490|5|True|738.0475|9|Positive|b18++|10|5|3|1029.5069|380|1380.0,Agilent6490|1|False|735.3761|41|Positive|y5+++|10|5|3|212.1403|380|3133.0,Agilent6490|2|False|735.3761|21|Positive|y9|10|5|3|1079.551|380|1925.0,Agilent6490|3|False|735.3761|13|Positive|y17++|10|5|3|1008.527|380|1699.0,Agilent6490|4|False|735.3761|17|Positive|y7|10|5|3|863.4763|380|1387.0,Agilent6490|5|False|735.3761|9|Positive|b18++|10|5|3|1029.5069|380|1380.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'STAISLFYELSENDLNFIK', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:19564.24 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'P58252', 'Assay Information': [{'GRAVY Score': '-1.04', 'CZE Purity': '100.00', 'Special Residues': 'R+10', 'Molecular Weight': '1147.51', 'AAA Concentration': '8.000000'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|574.7665|13|Positive|y7|10|5|2|856.4187|380|45936.0,Agilent6490|2|True|574.7665|13|Positive|b2|10|5|2|293.1132|380|31198.0,Agilent6490|3|True|574.7665|13|Positive|y6|10|5|2|670.3394|380|21053.0,Agilent6490|4|True|574.7665|21|Positive|y5|10|5|2|555.3125|380|20475.0,Agilent6490|5|True|574.7665|29|Positive|y2|10|5|2|256.1643|380|18099.0,Agilent6490|1|False|569.762|13|Positive|y7|10|5|2|846.41|380|45936.0,Agilent6490|2|False|569.762|13|Positive|b2|10|5|2|293.1132|380|31198.0,Agilent6490|3|False|569.762|13|Positive|y6|10|5|2|660.33|380|21053.0,Agilent6490|4|False|569.762|21|Positive|y5|10|5|2|545.3|380|20475.0,Agilent6490|5|False|569.762|29|Positive|y2|10|5|2|246.16|380|18099.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'YEWDVAEAR', 'Concentration Range': ['19564.24 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;12806.84 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;17661.84 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P58252', 'Assay Information': [{'GRAVY Score': '1.09', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '757.44', 'AAA Concentration': 'NA'}, {'GRAVY Score': '1.09', 'CZE Purity': '87.71', 'Special Residues': 'R+10', 'Molecular Weight': '767.44', 'AAA Concentration': '9.160000'}, {'GRAVY Score': '1.09', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '757.44', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|384.7343|5|Positive|b3|10|5|2|242.1499|380|311984.0,Agilent6490|2|True|384.7343|9|Positive|y5|10|5|2|527.3175|380|103667.0,Agilent6490|3|True|384.7343|9|Positive|y4|10|5|2|414.2335|380|93345.0,Agilent6490|4|True|384.7343|9|Positive|y3|10|5|2|343.1964|380|24565.0,Agilent6490|5|True|384.7343|5|Positive|y6++|10|5|2|320.7044|380|22245.0,Agilent6490|1|False|379.7343|5|Positive|b3|10|5|2|242.1499|380|311984.0,Agilent6490|2|False|379.7343|9|Positive|y5|10|5|2|517.3175|380|103667.0,Agilent6490|3|False|379.7343|9|Positive|y4|10|5|2|404.2335|380|93345.0,Agilent6490|4|False|379.7343|9|Positive|y3|10|5|2|333.1964|380|24565.0,Agilent6490|5|False|379.7343|5|Positive|y6++|10|5|2|315.7044|380|22245.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'AGIIASAR', 'Concentration Range': ['NA']}", "SubCellular": "Cytoplasm|Nucleus", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "AMPK signaling pathway|Oxytocin signaling pathway", "Protein": "Elongation factor 2", "UniProtKB Accession": "P58252"}, {"Human Gene": "PKM", "Mouse Go Name": "positive regulation of sprouting angiogenesis|magnesium ion binding|cytosol|cytoplasm|identical protein binding|animal organ regeneration|mitochondrion|potassium ion binding|ATP biosynthetic process|collagen-containing extracellular matrix|thyroid hormone binding|pyruvate kinase complex|kinase activity|myelin sheath|ATP binding|pyruvate biosynthetic process|programmed cell death|pyruvate kinase activity|skeletal muscle tissue regeneration|liver development|cellular response to insulin stimulus|glucose metabolic process|nucleus|photoreceptor inner segment|ADP binding|protein homotetramerization|glycolytic process|cilium", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "GSGTAEVELK<br>IENHEGVR<br>VVEVGSK<br>APIIAVTR", "Human UniProtKB Accession": "P14618", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "P52480-2", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P52480", "Assay Information": [{"GRAVY Score": "-0.34", "CZE Purity": "91.40", "Special Residues": "NA", "Molecular Weight": "989.5", "AAA Concentration": "NA"}, {"GRAVY Score": "-0.34", "CZE Purity": "74.46", "Special Residues": "K+8", "Molecular Weight": "997.5", "AAA Concentration": "5.670000"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|499.7664|17|Positive|y6|10|5|2|696.4018|380|31389.0,Agilent6490|2|True|499.7664|13|Positive|y8|10|5|2|854.4709|380|30104.0,Agilent6490|3|True|499.7664|25|Positive|y2|10|5|2|268.2111|380|27347.0,Agilent6490|4|True|499.7664|17|Positive|y5|10|5|2|625.3647|380|22851.0,Agilent6490|5|True|499.7664|9|Positive|b4|10|5|2|303.1299|380|17202.0,Agilent6490|1|False|495.7664|17|Positive|y6|10|5|2|688.4018|380|31389.0,Agilent6490|2|False|495.7664|13|Positive|y8|10|5|2|846.4709|380|30104.0,Agilent6490|3|False|495.7664|25|Positive|y2|10|5|2|260.2111|380|27347.0,Agilent6490|4|False|495.7664|17|Positive|y5|10|5|2|617.3647|380|22851.0,Agilent6490|5|False|495.7664|9|Positive|b4|10|5|2|303.1299|380|17202.0"], "Unique in protein": "Yes", "Peptide Sequence": "GSGTAEVELK", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "P52480-2", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:59381.7 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "P52480", "Assay Information": [{"GRAVY Score": "-1.24", "CZE Purity": "87.90", "Special Residues": "R+10", "Molecular Weight": "962.47", "AAA Concentration": "10.000000"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|321.8348|5|Positive|y7++|10|5|3|425.7057|380|11585.0,Agilent6490|2|True|321.8348|5|Positive|b5++|10|5|3|312.1428|380|8860.0,Agilent6490|3|True|321.8348|5|Positive|y5++|10|5|3|304.1629|380|5686.0,Agilent6490|4|True|321.8348|5|Positive|y6++|10|5|3|361.1844|380|5015.0,Agilent6490|5|True|321.8348|5|Positive|b2|10|5|3|243.1339|380|4043.0,Agilent6490|1|False|318.5015|5|Positive|y7++|10|5|3|420.7057|380|11585.0,Agilent6490|2|False|318.5015|5|Positive|b5++|10|5|3|312.1428|380|8860.0,Agilent6490|3|False|318.5015|5|Positive|y5++|10|5|3|299.1629|380|5686.0,Agilent6490|4|False|318.5015|5|Positive|y6++|10|5|3|356.1844|380|5015.0,Agilent6490|5|False|318.5015|5|Positive|b2|10|5|3|243.1339|380|4043.0"], "Unique in protein": "Yes", "Peptide Sequence": "IENHEGVR", "Concentration Range": ["59381.7 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;124149.3 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;386652.65 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "P52480-2", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P52480", "Assay Information": [{"GRAVY Score": "0.57", "CZE Purity": "100.00", "Special Residues": "K+8", "Molecular Weight": "724.41", "AAA Concentration": "11.000000"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|363.2184|9|Positive|y5|10|5|2|527.2915|380|57591.0,Agilent6490|2|True|363.2184|9|Positive|y6|10|5|2|626.3599|380|16778.0,Agilent6490|3|True|363.2184|17|Positive|y3|10|5|2|299.1805|380|12631.0,Agilent6490|4|True|363.2184|13|Positive|y4|10|5|2|398.2489|380|11103.0,Agilent6490|5|True|363.2184|5|Positive|b3|10|5|2|328.1867|380|9491.0,Agilent6490|1|False|359.2184|9|Positive|y5|10|5|2|519.2915|380|57591.0,Agilent6490|2|False|359.2184|9|Positive|y6|10|5|2|618.3599|380|16778.0,Agilent6490|3|False|359.2184|17|Positive|y3|10|5|2|291.1805|380|12631.0,Agilent6490|4|False|359.2184|13|Positive|y4|10|5|2|390.2489|380|11103.0,Agilent6490|5|False|359.2184|5|Positive|b3|10|5|2|328.1867|380|9491.0"], "Unique in protein": "Yes", "Peptide Sequence": "VVEVGSK", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "P52480-2", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:3143.32 (fmol/\u00b5L plasma)<br/>Mouse Plasma", "UniProtKB Accession": "P52480", "Assay Information": [{"GRAVY Score": "1.25", "CZE Purity": "65.00", "Special Residues": "R+10", "Molecular Weight": "849.52", "AAA Concentration": "9.000000"}], "Gradients": ["Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|425.7734|13|Positive|y5|10|5|2|569.3645|380|11529.0,Agilent6490|2|True|425.7734|9|Positive|y7++|10|5|2|390.2543|380|11484.0,Agilent6490|3|True|425.7734|9|Positive|y4|10|5|2|456.2804|380|8310.0,Agilent6490|4|True|425.7734|13|Positive|y6|10|5|2|682.4486|380|6147.0,Agilent6490|5|True|425.7734|17|Positive|y3|10|5|2|385.2433|380|2181.0,Agilent6490|1|False|420.77|13|Positive|y5|10|5|2|559.36|380|11529.0,Agilent6490|2|False|420.77|9|Positive|y7++|10|5|2|385.25|380|11484.0,Agilent6490|3|False|420.77|9|Positive|y4|10|5|2|446.27|380|8310.0,Agilent6490|4|False|420.77|13|Positive|y6|10|5|2|672.44|380|6147.0,Agilent6490|5|False|420.77|17|Positive|y3|10|5|2|375.23|380|2181.0"], "Unique in protein": "Yes", "Peptide Sequence": "APIIAVTR", "Concentration Range": ["3143.32 (fmol/\u00b5L plasma)|NA|NA|1|Mouse Plasma|Urea-based|Worthington Trypsin|6490|NA|NA|Female;190891.14 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;732492.32 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}], "Human ProteinName": "Pyruvate kinase PKM", "Human Go Name": "positive regulation of sprouting angiogenesis|magnesium ion binding|cytosol|cytoplasm|identical protein binding|MHC class II protein complex binding|animal organ regeneration|mitochondrion|potassium ion binding|ficolin-1-rich granule lumen|collagen-containing extracellular matrix|extracellular region|thyroid hormone binding|pyruvate kinase complex|kinase activity|myelin sheath|response to gravity|RNA binding|response to muscle inactivity|response to nutrient|programmed cell death|ATP binding|pyruvate kinase activity|response to hypoxia|skeletal muscle tissue regeneration|liver development|cadherin binding|vesicle|cellular response to insulin stimulus|nucleus|extracellular vesicle|secretory granule lumen|extracellular exosome|ADP binding|canonical glycolysis|protein homotetramerization|glycolytic process|cilium|neutrophil degranulation", "Human Drug Bank": "<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB01733\">L-Phospholactate</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB00119\">Pyruvic acid</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB02726\">2-Phosphoglycolic Acid</a>", "Biological Matrix": "Mouse Brain<br/>Mouse Plasma<br/>Mouse Heart", "Human Kegg Pathway Name": "Pyruvate metabolism|Carbon metabolism|Purine metabolism|Glycolysis / Gluconeogenesis|Central carbon metabolism in cancer|Type II diabetes mellitus|Glucagon signaling pathway|Biosynthesis of amino acids|Metabolic pathways|Viral carcinogenesis|Human papillomavirus infection", "Biological Matrix Details": [["59381.7 (fmol/\u00b5g Lung)", "Female", "IENHEGVR", "P52480", "Mouse Lung"], ["3143.32 (fmol/\u00b5L plasma)", "Female", "APIIAVTR", "P52480", "Mouse Plasma"], ["190891.14 (fmol/\u00b5g Heart)", "Female", "APIIAVTR", "P52480", "Mouse Heart"], ["732492.32 (fmol/\u00b5g Brain)", "Female", "APIIAVTR", "P52480", "Mouse Brain"]], "Gene": "Pkm", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'P52480-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P52480', 'Assay Information': [{'GRAVY Score': '-0.34', 'CZE Purity': '91.40', 'Special Residues': 'NA', 'Molecular Weight': '989.5', 'AAA Concentration': 'NA'}, {'GRAVY Score': '-0.34', 'CZE Purity': '74.46', 'Special Residues': 'K+8', 'Molecular Weight': '997.5', 'AAA Concentration': '5.670000'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|499.7664|17|Positive|y6|10|5|2|696.4018|380|31389.0,Agilent6490|2|True|499.7664|13|Positive|y8|10|5|2|854.4709|380|30104.0,Agilent6490|3|True|499.7664|25|Positive|y2|10|5|2|268.2111|380|27347.0,Agilent6490|4|True|499.7664|17|Positive|y5|10|5|2|625.3647|380|22851.0,Agilent6490|5|True|499.7664|9|Positive|b4|10|5|2|303.1299|380|17202.0,Agilent6490|1|False|495.7664|17|Positive|y6|10|5|2|688.4018|380|31389.0,Agilent6490|2|False|495.7664|13|Positive|y8|10|5|2|846.4709|380|30104.0,Agilent6490|3|False|495.7664|25|Positive|y2|10|5|2|260.2111|380|27347.0,Agilent6490|4|False|495.7664|17|Positive|y5|10|5|2|617.3647|380|22851.0,Agilent6490|5|False|495.7664|9|Positive|b4|10|5|2|303.1299|380|17202.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'GSGTAEVELK', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'P52480-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:59381.7 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'P52480', 'Assay Information': [{'GRAVY Score': '-1.24', 'CZE Purity': '87.90', 'Special Residues': 'R+10', 'Molecular Weight': '962.47', 'AAA Concentration': '10.000000'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|321.8348|5|Positive|y7++|10|5|3|425.7057|380|11585.0,Agilent6490|2|True|321.8348|5|Positive|b5++|10|5|3|312.1428|380|8860.0,Agilent6490|3|True|321.8348|5|Positive|y5++|10|5|3|304.1629|380|5686.0,Agilent6490|4|True|321.8348|5|Positive|y6++|10|5|3|361.1844|380|5015.0,Agilent6490|5|True|321.8348|5|Positive|b2|10|5|3|243.1339|380|4043.0,Agilent6490|1|False|318.5015|5|Positive|y7++|10|5|3|420.7057|380|11585.0,Agilent6490|2|False|318.5015|5|Positive|b5++|10|5|3|312.1428|380|8860.0,Agilent6490|3|False|318.5015|5|Positive|y5++|10|5|3|299.1629|380|5686.0,Agilent6490|4|False|318.5015|5|Positive|y6++|10|5|3|356.1844|380|5015.0,Agilent6490|5|False|318.5015|5|Positive|b2|10|5|3|243.1339|380|4043.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'IENHEGVR', 'Concentration Range': ['59381.7 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;124149.3 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;386652.65 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'P52480-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P52480', 'Assay Information': [{'GRAVY Score': '0.57', 'CZE Purity': '100.00', 'Special Residues': 'K+8', 'Molecular Weight': '724.41', 'AAA Concentration': '11.000000'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|363.2184|9|Positive|y5|10|5|2|527.2915|380|57591.0,Agilent6490|2|True|363.2184|9|Positive|y6|10|5|2|626.3599|380|16778.0,Agilent6490|3|True|363.2184|17|Positive|y3|10|5|2|299.1805|380|12631.0,Agilent6490|4|True|363.2184|13|Positive|y4|10|5|2|398.2489|380|11103.0,Agilent6490|5|True|363.2184|5|Positive|b3|10|5|2|328.1867|380|9491.0,Agilent6490|1|False|359.2184|9|Positive|y5|10|5|2|519.2915|380|57591.0,Agilent6490|2|False|359.2184|9|Positive|y6|10|5|2|618.3599|380|16778.0,Agilent6490|3|False|359.2184|17|Positive|y3|10|5|2|291.1805|380|12631.0,Agilent6490|4|False|359.2184|13|Positive|y4|10|5|2|390.2489|380|11103.0,Agilent6490|5|False|359.2184|5|Positive|b3|10|5|2|328.1867|380|9491.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'VVEVGSK', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'P52480-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:3143.32 (fmol/\\xc2\\xb5L plasma)<br/>Mouse Plasma', 'UniProtKB Accession': 'P52480', 'Assay Information': [{'GRAVY Score': '1.25', 'CZE Purity': '65.00', 'Special Residues': 'R+10', 'Molecular Weight': '849.52', 'AAA Concentration': '9.000000'}], 'Gradients': ['Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|425.7734|13|Positive|y5|10|5|2|569.3645|380|11529.0,Agilent6490|2|True|425.7734|9|Positive|y7++|10|5|2|390.2543|380|11484.0,Agilent6490|3|True|425.7734|9|Positive|y4|10|5|2|456.2804|380|8310.0,Agilent6490|4|True|425.7734|13|Positive|y6|10|5|2|682.4486|380|6147.0,Agilent6490|5|True|425.7734|17|Positive|y3|10|5|2|385.2433|380|2181.0,Agilent6490|1|False|420.77|13|Positive|y5|10|5|2|559.36|380|11529.0,Agilent6490|2|False|420.77|9|Positive|y7++|10|5|2|385.25|380|11484.0,Agilent6490|3|False|420.77|9|Positive|y4|10|5|2|446.27|380|8310.0,Agilent6490|4|False|420.77|13|Positive|y6|10|5|2|672.44|380|6147.0,Agilent6490|5|False|420.77|17|Positive|y3|10|5|2|375.23|380|2181.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'APIIAVTR', 'Concentration Range': ['3143.32 (fmol/\\xc2\\xb5L plasma)|NA|NA|1|Mouse Plasma|Urea-based|Worthington Trypsin|6490|NA|NA|Female;190891.14 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;732492.32 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']}", "SubCellular": "Cytoplasm|Nucleus", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Pyruvate metabolism|Carbon metabolism|Purine metabolism|Glycolysis / Gluconeogenesis|Central carbon metabolism in cancer|Type II diabetes mellitus|Glucagon signaling pathway|Biosynthesis of amino acids|Metabolic pathways|Viral carcinogenesis|Human papillomavirus infection", "Protein": "Pyruvate kinase PKM", "UniProtKB Accession": "P52480"}, {"Human Gene": "KLHL41", "Mouse Go Name": "endoplasmic reticulum membrane|M band|pseudopodium|sarcoplasmic reticulum membrane|cytosol|cytoplasm|regulation of lateral pseudopodium assembly|myofibril assembly|skeletal muscle fiber development|Cul3-RING ubiquitin ligase complex|skeletal muscle cell differentiation|regulation of myoblast proliferation|nucleus|regulation of skeletal muscle cell differentiation|regulation of myoblast differentiation|protein ubiquitination|ruffle|cytoskeleton|sarcomere organization|plasma membrane", "Human Disease Name": "Nemaline myopathy 9(NEM9)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "LYQSTLLQDGLK", "Human UniProtKB Accession": "O60662", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "A2AUC9", "Assay Information": [{"GRAVY Score": "-0.20", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1377.75", "AAA Concentration": "NA"}, {"GRAVY Score": "-0.20", "CZE Purity": "82.91", "Special Residues": "K+8", "Molecular Weight": "1385.75", "AAA Concentration": "8.370000"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6495|2|False|460.2574|9|Positive|y6|10|5|3|673.3879|380|2.0,Agilent6495|1|False|460.2574|9|Positive|y5|10|5|3|560.3039|380|1.0,Agilent6495|3|False|460.2574|9|Positive|y6++|10|5|3|337.1976|380|3.0,Agilent6495|5|False|460.2574|9|Positive|b5|10|5|3|593.293|380|5.0,Agilent6495|4|False|460.2574|9|Positive|b6|10|5|3|706.377|380|4.0,Agilent6495|2|True|462.9288|9|Positive|y6|10|5|3|681.4021|380|2.0,Agilent6495|1|True|462.9288|9|Positive|y5|10|5|3|568.3181|380|1.0,Agilent6495|3|True|462.9288|9|Positive|y6++|10|5|3|341.2047|380|3.0,Agilent6495|5|True|462.9288|9|Positive|b5|10|5|3|593.293|380|5.0,Agilent6495|4|True|462.9288|9|Positive|b6|10|5|3|706.377|380|4.0"], "Unique in protein": "Yes", "Peptide Sequence": "LYQSTLLQDGLK", "Concentration Range": ["NA"]}], "Human ProteinName": "Kelch-like protein 41", "Human Go Name": "pseudopodium|regulation of lateral pseudopodium assembly|cytosol|cytoplasm|protein ubiquitination|M band|cytoskeleton|striated muscle contraction|plasma membrane|regulation of myoblast proliferation|regulation of myoblast differentiation|endoplasmic reticulum membrane|ruffle|sarcoplasmic reticulum membrane|myofibril assembly|skeletal muscle cell differentiation|nucleus|sarcomere organization|skeletal muscle fiber development|Cul3-RING ubiquitin ligase complex|post-translational protein modification|regulation of skeletal muscle cell differentiation", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "NA", "Biological Matrix Details": [], "Gene": "Klhl41", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'A2AUC9', 'Assay Information': [{'GRAVY Score': '-0.20', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1377.75', 'AAA Concentration': 'NA'}, {'GRAVY Score': '-0.20', 'CZE Purity': '82.91', 'Special Residues': 'K+8', 'Molecular Weight': '1385.75', 'AAA Concentration': '8.370000'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6495|2|False|460.2574|9|Positive|y6|10|5|3|673.3879|380|2.0,Agilent6495|1|False|460.2574|9|Positive|y5|10|5|3|560.3039|380|1.0,Agilent6495|3|False|460.2574|9|Positive|y6++|10|5|3|337.1976|380|3.0,Agilent6495|5|False|460.2574|9|Positive|b5|10|5|3|593.293|380|5.0,Agilent6495|4|False|460.2574|9|Positive|b6|10|5|3|706.377|380|4.0,Agilent6495|2|True|462.9288|9|Positive|y6|10|5|3|681.4021|380|2.0,Agilent6495|1|True|462.9288|9|Positive|y5|10|5|3|568.3181|380|1.0,Agilent6495|3|True|462.9288|9|Positive|y6++|10|5|3|341.2047|380|3.0,Agilent6495|5|True|462.9288|9|Positive|b5|10|5|3|593.293|380|5.0,Agilent6495|4|True|462.9288|9|Positive|b6|10|5|3|706.377|380|4.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'LYQSTLLQDGLK', 'Concentration Range': ['NA']}", "SubCellular": "Endoplasmic reticulum membrane|Cytoplasm|Cell projection|Sarcoplasmic reticulum membrane", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "Kelch-like protein 41", "UniProtKB Accession": "A2AUC9"}, {"Human Gene": "OBSCN", "Mouse Go Name": "cytosol|nuclear body|intercalated disc|ankyrin binding|titin binding|plasma membrane|extracellular space|protein kinase activity|calmodulin binding|ATP binding|multicellular organism development|protein autophosphorylation|striated muscle myosin thick filament|regulation of Rho protein signal transduction|metal ion binding|M band|cadherin binding|sarcomere|protein phosphorylation|Z disc|cell differentiation|sarcolemma|protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "HEATSLGDTHTLTVR", "Human UniProtKB Accession": "Q5VST9", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "A2AAJ9-2", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "A2AAJ9", "Assay Information": [{"GRAVY Score": "-0.55", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1636.82", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["NA"], "Unique in protein": "Yes", "Peptide Sequence": "HEATSLGDTHTLTVR", "Concentration Range": ["NA"]}], "Human ProteinName": "Obscurin", "Human Go Name": "protein localization to M-band|cytosol|nuclear body|structural constituent of muscle|G protein-coupled receptor signaling pathway|ankyrin binding|titin binding|plasma membrane|sarcomere organization|positive regulation of apoptotic process|calmodulin binding|ATP binding|multicellular organism development|regulation of Rho protein signal transduction|metal ion binding|M band|regulation of small GTPase mediated signal transduction|myofibril|Z disc|guanyl-nucleotide exchange factor activity|sarcolemma|protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "NA", "Biological Matrix Details": [], "Gene": "Obscn", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'A2AAJ9-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'A2AAJ9', 'Assay Information': [{'GRAVY Score': '-0.55', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1636.82', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['NA'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'HEATSLGDTHTLTVR', 'Concentration Range': ['NA']}", "SubCellular": "Cytoplasm|Nucleus|Cell membrane|Secreted", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "Obscurin", "UniProtKB Accession": "A2AAJ9"}, {"Human Gene": "GNAI1", "Mouse Go Name": "plasma membrane|G-protein beta/gamma-subunit complex binding|magnesium ion binding|cellular response to forskolin|cytoplasm|G protein-coupled receptor signaling pathway|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|G protein-coupled receptor binding|cell division|centrosome|GTPase activating protein binding|membrane|positive regulation of protein localization to cell cortex|regulation of cAMP-mediated signaling|membrane raft|cell cortex region|nucleus|GTP binding|regulation of mitotic spindle organization|heterotrimeric G-protein complex|G protein-coupled serotonin receptor binding|midbody|nucleolus|protein-containing complex|GDP binding|negative regulation of synaptic transmission|GTPase activity|cell cycle", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "IAQPNYIPTQQDVLR", "Human UniProtKB Accession": "P63096", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "B2RSH2", "Assay Information": [{"GRAVY Score": "-0.56", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1754.93", "AAA Concentration": "NA"}, {"GRAVY Score": "-0.56", "CZE Purity": "91.92", "Special Residues": "R+10", "Molecular Weight": "1764.93", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6495|5|False|878.473|33|Positive|y9|10|5|2|1069.6|380|5.0,Agilent6495|1|False|878.473|33|Positive|y8|10|5|2|956.516|380|1.0,Agilent6495|2|False|878.473|29|Positive|y12++|10|5|2|722.3832|380|2.0,Agilent6495|3|False|878.473|29|Positive|b3|10|5|2|313.187|380|3.0,Agilent6495|4|False|878.473|25|Positive|b7|10|5|2|800.4301|380|4.0,Agilent6495|5|True|883.4772|33|Positive|y9|10|5|2|1079.6083|380|5.0,Agilent6495|1|True|883.4772|33|Positive|y8|10|5|2|966.5242|380|1.0,Agilent6495|2|True|883.4772|29|Positive|y12++|10|5|2|727.3873|380|2.0,Agilent6495|3|True|883.4772|29|Positive|b3|10|5|2|313.187|380|3.0,Agilent6495|4|True|883.4772|25|Positive|b7|10|5|2|800.4301|380|4.0"], "Unique in protein": "Yes", "Peptide Sequence": "IAQPNYIPTQQDVLR", "Concentration Range": ["NA"]}], "Human ProteinName": "Guanine nucleotide-binding protein G(i) subunit alpha-1", "Human Go Name": "G-protein beta/gamma-subunit complex binding|magnesium ion binding|cellular response to forskolin|cytoplasm|G protein-coupled receptor signaling pathway|plasma membrane|G protein-coupled receptor binding|cell division|protein folding|centrosome|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|positive regulation of protein localization to cell cortex|regulation of cAMP-mediated signaling|cell cortex region|lysosomal membrane|nucleus|GTP binding|regulation of mitotic spindle organization|heterotrimeric G-protein complex|G protein-coupled serotonin receptor binding|midbody|extracellular exosome|nucleolus|GDP binding|GTPase activity|response to peptide hormone|cell cycle", "Human Drug Bank": "<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB04315\">Guanosine-5'-Diphosphate</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB04444\">Tetrafluoroaluminate Ion</a>", "Biological Matrix": "NA", "Human Kegg Pathway Name": "Toxoplasmosis|Glutamatergic synapse|Human immunodeficiency virus 1 infection|Axon guidance|Relaxin signaling pathway|cGMP-PKG signaling pathway|Retrograde endocannabinoid signaling|Cushing syndrome|Melanogenesis|Alcoholism|GABAergic synapse|Regulation of lipolysis in adipocytes|Parathyroid hormone synthesis, secretion and action|Rap1 signaling pathway|cAMP signaling pathway|Leukocyte transendothelial migration|Oxytocin signaling pathway|Circadian entrainment|Gastric acid secretion|Platelet activation|Dopaminergic synapse|Morphine addiction|Cholinergic synapse|Serotonergic synapse|Apelin signaling pathway|Long-term depression|Parkinson disease|Pathways in cancer|Chemokine signaling pathway|Chagas disease (American trypanosomiasis)|Pertussis|Human cytomegalovirus infection|Sphingolipid signaling pathway|Renin secretion|Gap junction|Estrogen signaling pathway|Cocaine addiction|Adrenergic signaling in cardiomyocytes|Progesterone-mediated oocyte maturation", "Biological Matrix Details": [], "Gene": "Gnai1", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'B2RSH2', 'Assay Information': [{'GRAVY Score': '-0.56', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1754.93', 'AAA Concentration': 'NA'}, {'GRAVY Score': '-0.56', 'CZE Purity': '91.92', 'Special Residues': 'R+10', 'Molecular Weight': '1764.93', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6495|5|False|878.473|33|Positive|y9|10|5|2|1069.6|380|5.0,Agilent6495|1|False|878.473|33|Positive|y8|10|5|2|956.516|380|1.0,Agilent6495|2|False|878.473|29|Positive|y12++|10|5|2|722.3832|380|2.0,Agilent6495|3|False|878.473|29|Positive|b3|10|5|2|313.187|380|3.0,Agilent6495|4|False|878.473|25|Positive|b7|10|5|2|800.4301|380|4.0,Agilent6495|5|True|883.4772|33|Positive|y9|10|5|2|1079.6083|380|5.0,Agilent6495|1|True|883.4772|33|Positive|y8|10|5|2|966.5242|380|1.0,Agilent6495|2|True|883.4772|29|Positive|y12++|10|5|2|727.3873|380|2.0,Agilent6495|3|True|883.4772|29|Positive|b3|10|5|2|313.187|380|3.0,Agilent6495|4|True|883.4772|25|Positive|b7|10|5|2|800.4301|380|4.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'IAQPNYIPTQQDVLR', 'Concentration Range': ['NA']}", "SubCellular": "Cytoplasm|Nucleus|Cell membrane|Membrane", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Toxoplasmosis|Cholinergic synapse|Human immunodeficiency virus 1 infection|Axon guidance|Relaxin signaling pathway|cGMP-PKG signaling pathway|Retrograde endocannabinoid signaling|Cushing syndrome|Melanogenesis|Alcoholism|GABAergic synapse|Regulation of lipolysis in adipocytes|Parathyroid hormone synthesis, secretion and action|Rap1 signaling pathway|cAMP signaling pathway|Leukocyte transendothelial migration|Oxytocin signaling pathway|Morphine addiction|Parkinson disease|Platelet activation|Dopaminergic synapse|Glutamatergic synapse|Serotonergic synapse|Apelin signaling pathway|Long-term depression|Circadian entrainment|Gastric acid secretion|Pathways in cancer|Chemokine signaling pathway|Chagas disease (American trypanosomiasis)|Pertussis|Human cytomegalovirus infection|Sphingolipid signaling pathway|Renin secretion|Gap junction|Estrogen signaling pathway|Cocaine addiction|Adrenergic signaling in cardiomyocytes|Progesterone-mediated oocyte maturation", "Protein": "Guanine nucleotide-binding protein G(i) subunit alpha-1", "UniProtKB Accession": "B2RSH2"}, {"Human Gene": "CUL4B", "Mouse Go Name": "proteasomal protein catabolic process|UV-damage excision repair|damaged DNA binding|cullin-RING ubiquitin ligase complex|neuron projection development|ubiquitin-dependent protein catabolic process|cytosol|cellular response to DNA damage stimulus|Cul4-RING E3 ubiquitin ligase complex|nucleoplasm|protein ubiquitination|ubiquitin protein ligase binding|nucleus|histone H2A monoubiquitination|Cul4B-RING E3 ubiquitin ligase complex|cell cycle|positive regulation of G1/S transition of mitotic cell cycle|positive regulation of protein catabolic process", "Human Disease Name": "Mental retardation, X-linked, syndromic, 15(MRXS15)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "ETVEEQASTTER", "Human UniProtKB Accession": "Q13620", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "A2A432-2", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "A2A432", "Assay Information": [{"GRAVY Score": "-1.57", "CZE Purity": "93.48", "Special Residues": "R+10", "Molecular Weight": "1388.62", "AAA Concentration": "10.620000"}], "Gradients": ["NA"], "Transitions": ["NA"], "Unique in protein": "Yes", "Peptide Sequence": "ETVEEQASTTER", "Concentration Range": ["NA"]}], "Human ProteinName": "Cullin-4B", "Human Go Name": "cullin-RING ubiquitin ligase complex|neuron projection development|cytosol|nucleotide-excision repair, DNA incision, 5'-to lesion|DNA damage response, detection of DNA damage|protein ubiquitination|positive regulation of G1/S transition of mitotic cell cycle|nucleotide-excision repair, preincision complex stabilization|cellular response to DNA damage stimulus|nucleoplasm|ubiquitin protein ligase binding|UV-damage excision repair|global genome nucleotide-excision repair|nucleotide-excision repair, DNA damage recognition|Cul4B-RING E3 ubiquitin ligase complex|extracellular exosome|proteasomal protein catabolic process|transcription-coupled nucleotide-excision repair|G1/S transition of mitotic cell cycle|nucleotide-excision repair, DNA incision|Cul4-RING E3 ubiquitin ligase complex|nucleotide-excision repair, preincision complex assembly|histone H2A monoubiquitination|post-translational protein modification|ubiquitin-dependent protein catabolic process|positive regulation of protein catabolic process", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "Human immunodeficiency virus 1 infection|Ubiquitin mediated proteolysis|Nucleotide excision repair", "Biological Matrix Details": [], "Gene": "Cul4b", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'A2A432-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'A2A432', 'Assay Information': [{'GRAVY Score': '-1.57', 'CZE Purity': '93.48', 'Special Residues': 'R+10', 'Molecular Weight': '1388.62', 'AAA Concentration': '10.620000'}], 'Gradients': ['NA'], 'Transitions': ['NA'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'ETVEEQASTTER', 'Concentration Range': ['NA']}", "SubCellular": "Nucleus", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Human immunodeficiency virus 1 infection|Ubiquitin mediated proteolysis|Nucleotide excision repair", "Protein": "Cullin-4B", "UniProtKB Accession": "A2A432"}, {"Human Gene": "MED14", "Mouse Go Name": "stem cell population maintenance|signaling receptor activity|transcription initiation from RNA polymerase II promoter|positive regulation of transcription by RNA polymerase II|androgen receptor signaling pathway|nucleoplasm|mediator complex|transcription coactivator activity|transcription coregulator activity|nucleus|intracellular steroid hormone receptor signaling pathway|positive regulation of transcription, DNA-templated|core mediator complex", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "LLIDSVHAR", "Human UniProtKB Accession": "O60244", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "A2ABV5-4,A2ABV5-2,A2ABV5-3", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "A2ABV5", "Assay Information": [{"GRAVY Score": "0.68", "CZE Purity": "90.71", "Special Residues": "R+10", "Molecular Weight": "1032.59", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["NA"], "Unique in protein": "Yes", "Peptide Sequence": "LLIDSVHAR", "Concentration Range": ["NA"]}], "Human ProteinName": "Mediator of RNA polymerase II transcription subunit 14", "Human Go Name": "nuclear receptor transcription coactivator activity|signaling receptor activity|transcription initiation from RNA polymerase II promoter|positive regulation of transcription by RNA polymerase II|transcription coregulator activity|nucleoplasm|vitamin D receptor binding|positive regulation of transcription, DNA-templated|mediator complex|transcription coactivator activity|androgen receptor signaling pathway|nucleus|membrane|intracellular steroid hormone receptor signaling pathway|regulation of transcription by RNA polymerase II|stem cell population maintenance|core mediator complex", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "Thyroid hormone signaling pathway", "Biological Matrix Details": [], "Gene": "Med14", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'A2ABV5-4,A2ABV5-2,A2ABV5-3', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'A2ABV5', 'Assay Information': [{'GRAVY Score': '0.68', 'CZE Purity': '90.71', 'Special Residues': 'R+10', 'Molecular Weight': '1032.59', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['NA'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'LLIDSVHAR', 'Concentration Range': ['NA']}", "SubCellular": "Nucleus", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Thyroid hormone signaling pathway", "Protein": "Mediator of RNA polymerase II transcription subunit 14", "UniProtKB Accession": "A2ABV5"}, {"Human Gene": "PEPD", "Mouse Go Name": "proline dipeptidase activity|aminopeptidase activity|nucleoplasm|peptidase activity|collagen catabolic process|nucleus|manganese ion binding|metallopeptidase activity", "Human Disease Name": "Prolidase deficiency(PD)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "YAVDDVQYTDEIASVLTSR<br>STLFVPR", "Human UniProtKB Accession": "P12955", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "Q11136", "Assay Information": [{"GRAVY Score": "-0.16", "CZE Purity": "71.87", "Special Residues": "R+10", "Molecular Weight": "2154.03", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|719.0197|21|Positive|y4|10|5|3|486.291|380|55878.0,Agilent6490|2|True|719.0197|21|Positive|y7|10|5|3|743.4286|380|49927.0,Agilent6490|3|True|719.0197|17|Positive|y6|10|5|3|672.3914|380|48888.0,Agilent6490|4|True|719.0197|13|Positive|b13++|10|5|3|742.333|380|34958.0,Agilent6490|5|True|719.0197|9|Positive|b16++|10|5|3|891.9253|380|33764.0,Agilent6490|1|False|715.6864|21|Positive|y4|10|5|3|476.291|380|55878.0,Agilent6490|2|False|715.6864|21|Positive|y7|10|5|3|733.4286|380|49927.0,Agilent6490|3|False|715.6864|17|Positive|y6|10|5|3|662.3914|380|48888.0,Agilent6490|4|False|715.6864|13|Positive|b13++|10|5|3|742.333|380|34958.0,Agilent6490|5|False|715.6864|9|Positive|b16++|10|5|3|891.9253|380|33764.0"], "Unique in protein": "Yes", "Peptide Sequence": "YAVDDVQYTDEIASVLTSR", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:1344.16 (fmol/\u00b5g Brain)<br/>Mouse Brain", "UniProtKB Accession": "Q11136", "Assay Information": [{"GRAVY Score": "0.46", "CZE Purity": "95.97", "Special Residues": "R+10", "Molecular Weight": "828.47", "AAA Concentration": "NA"}, {"GRAVY Score": "0.46", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "818.47", "AAA Concentration": "NA"}, {"GRAVY Score": "0.46", "CZE Purity": "97.99", "Special Residues": "R+10", "Molecular Weight": "828.47", "AAA Concentration": "8.000000"}], "Gradients": ["NA", "Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|415.2445|9|Positive|y4|10|5|2|528.3168|380|128699.0,Agilent6490|2|True|415.2445|9|Positive|y5|10|5|2|641.4009|380|69504.0,Agilent6490|3|True|415.2445|9|Positive|y3|10|5|2|381.2484|380|44532.0,Agilent6490|4|True|415.2445|9|Positive|y5++|10|5|2|321.2041|380|33255.0,Agilent6490|5|True|415.2445|17|Positive|y2|10|5|2|282.18|380|27796.0,Agilent6490|1|False|410.239|9|Positive|y4|10|5|2|518.31|380|128699.0,Agilent6490|2|False|410.239|9|Positive|y5|10|5|2|631.39|380|69504.0,Agilent6490|3|False|410.239|9|Positive|y3|10|5|2|371.24|380|44532.0,Agilent6490|4|False|410.239|9|Positive|y5++|10|5|2|316.2|380|33255.0,Agilent6490|5|False|410.239|17|Positive|y2|10|5|2|272.17|380|27796.0"], "Unique in protein": "Yes", "Peptide Sequence": "STLFVPR", "Concentration Range": ["NA", "1344.16 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}], "Human ProteinName": "Xaa-Pro dipeptidase", "Human Go Name": "proline dipeptidase activity|cellular amino acid metabolic process|aminopeptidase activity|nucleoplasm|collagen catabolic process|nucleus|manganese ion binding|metallocarboxypeptidase activity|proteolysis|extracellular exosome", "Human Drug Bank": "NA", "Biological Matrix": "Mouse Brain", "Human Kegg Pathway Name": "NA", "Biological Matrix Details": [["1344.16 (fmol/\u00b5g Brain)", "Female", "STLFVPR", "Q11136", "Mouse Brain"]], "Gene": "Pepd", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'Q11136', 'Assay Information': [{'GRAVY Score': '-0.16', 'CZE Purity': '71.87', 'Special Residues': 'R+10', 'Molecular Weight': '2154.03', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|719.0197|21|Positive|y4|10|5|3|486.291|380|55878.0,Agilent6490|2|True|719.0197|21|Positive|y7|10|5|3|743.4286|380|49927.0,Agilent6490|3|True|719.0197|17|Positive|y6|10|5|3|672.3914|380|48888.0,Agilent6490|4|True|719.0197|13|Positive|b13++|10|5|3|742.333|380|34958.0,Agilent6490|5|True|719.0197|9|Positive|b16++|10|5|3|891.9253|380|33764.0,Agilent6490|1|False|715.6864|21|Positive|y4|10|5|3|476.291|380|55878.0,Agilent6490|2|False|715.6864|21|Positive|y7|10|5|3|733.4286|380|49927.0,Agilent6490|3|False|715.6864|17|Positive|y6|10|5|3|662.3914|380|48888.0,Agilent6490|4|False|715.6864|13|Positive|b13++|10|5|3|742.333|380|34958.0,Agilent6490|5|False|715.6864|9|Positive|b16++|10|5|3|891.9253|380|33764.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'YAVDDVQYTDEIASVLTSR', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:1344.16 (fmol/\\xc2\\xb5g Brain)<br/>Mouse Brain', 'UniProtKB Accession': 'Q11136', 'Assay Information': [{'GRAVY Score': '0.46', 'CZE Purity': '95.97', 'Special Residues': 'R+10', 'Molecular Weight': '828.47', 'AAA Concentration': 'NA'}, {'GRAVY Score': '0.46', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '818.47', 'AAA Concentration': 'NA'}, {'GRAVY Score': '0.46', 'CZE Purity': '97.99', 'Special Residues': 'R+10', 'Molecular Weight': '828.47', 'AAA Concentration': '8.000000'}], 'Gradients': ['NA', 'Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|415.2445|9|Positive|y4|10|5|2|528.3168|380|128699.0,Agilent6490|2|True|415.2445|9|Positive|y5|10|5|2|641.4009|380|69504.0,Agilent6490|3|True|415.2445|9|Positive|y3|10|5|2|381.2484|380|44532.0,Agilent6490|4|True|415.2445|9|Positive|y5++|10|5|2|321.2041|380|33255.0,Agilent6490|5|True|415.2445|17|Positive|y2|10|5|2|282.18|380|27796.0,Agilent6490|1|False|410.239|9|Positive|y4|10|5|2|518.31|380|128699.0,Agilent6490|2|False|410.239|9|Positive|y5|10|5|2|631.39|380|69504.0,Agilent6490|3|False|410.239|9|Positive|y3|10|5|2|371.24|380|44532.0,Agilent6490|4|False|410.239|9|Positive|y5++|10|5|2|316.2|380|33255.0,Agilent6490|5|False|410.239|17|Positive|y2|10|5|2|272.17|380|27796.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'STLFVPR', 'Concentration Range': ['NA', '1344.16 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']}", "SubCellular": "NA", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "Xaa-Pro dipeptidase", "UniProtKB Accession": "Q11136"}, {"Human Gene": "THOC2", "Mouse Go Name": "negative regulation of neuron projection development|generation of neurons|blastocyst development|stem cell division|neuron development|RNA splicing|mRNA processing|regulation of gene expression|nuclear speck|regulation of mRNA export from nucleus|nucleus|THO complex part of transcription export complex|THO complex|mRNA binding|poly(A)+ mRNA export from nucleus|mRNA export from nucleus|viral mRNA export from host cell nucleus|transcription export complex|cell morphogenesis", "Human Disease Name": "Mental retardation, X-linked 12(MRX12)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "TPATTPEAR", "Human UniProtKB Accession": "Q8NI27", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "B1AZI6", "Assay Information": [{"GRAVY Score": "-1.08", "CZE Purity": "89.76", "Special Residues": "R+10", "Molecular Weight": "952.48", "AAA Concentration": "NA"}, {"GRAVY Score": "-1.08", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "942.48", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|2|False|472.2458|21|Positive|y7|10|5|2|745.3839|380|2.0,Agilent6490|3|False|472.2458|21|Positive|y6|10|5|2|674.3468|380|3.0,Agilent6490|4|False|472.2458|17|Positive|y5|10|5|2|573.2991|380|4.0,Agilent6490|5|False|472.2458|29|Positive|y2|10|5|2|246.1561|380|5.0,Agilent6490|1|False|472.2458|17|Positive|y8++|10|5|2|421.722|380|1.0,Agilent6490|2|True|477.2499|21|Positive|y7|10|5|2|755.3922|380|2.0,Agilent6490|3|True|477.2499|21|Positive|y6|10|5|2|684.355|380|3.0,Agilent6490|4|True|477.2499|17|Positive|y5|10|5|2|583.3074|380|4.0,Agilent6490|5|True|477.2499|29|Positive|y2|10|5|2|256.1643|380|5.0,Agilent6490|1|True|477.2499|17|Positive|y8++|10|5|2|426.7261|380|1.0"], "Unique in protein": "Yes", "Peptide Sequence": "TPATTPEAR", "Concentration Range": ["NA"]}], "Human ProteinName": "THO complex subunit 2", "Human Go Name": "RNA export from nucleus|generation of neurons|mRNA export from nucleus|nucleoplasm|RNA splicing|neuron development|nuclear speck|THO complex part of transcription export complex|mRNA 3'-end processing|THO complex|mRNA binding|poly(A)+ mRNA export from nucleus|viral mRNA export from host cell nucleus|transcription export complex", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "Spliceosome|RNA transport", "Biological Matrix Details": [], "Gene": "Thoc2", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'B1AZI6', 'Assay Information': [{'GRAVY Score': '-1.08', 'CZE Purity': '89.76', 'Special Residues': 'R+10', 'Molecular Weight': '952.48', 'AAA Concentration': 'NA'}, {'GRAVY Score': '-1.08', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '942.48', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|2|False|472.2458|21|Positive|y7|10|5|2|745.3839|380|2.0,Agilent6490|3|False|472.2458|21|Positive|y6|10|5|2|674.3468|380|3.0,Agilent6490|4|False|472.2458|17|Positive|y5|10|5|2|573.2991|380|4.0,Agilent6490|5|False|472.2458|29|Positive|y2|10|5|2|246.1561|380|5.0,Agilent6490|1|False|472.2458|17|Positive|y8++|10|5|2|421.722|380|1.0,Agilent6490|2|True|477.2499|21|Positive|y7|10|5|2|755.3922|380|2.0,Agilent6490|3|True|477.2499|21|Positive|y6|10|5|2|684.355|380|3.0,Agilent6490|4|True|477.2499|17|Positive|y5|10|5|2|583.3074|380|4.0,Agilent6490|5|True|477.2499|29|Positive|y2|10|5|2|256.1643|380|5.0,Agilent6490|1|True|477.2499|17|Positive|y8++|10|5|2|426.7261|380|1.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'TPATTPEAR', 'Concentration Range': ['NA']}", "SubCellular": "Nucleus speckle|Nucleus", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Spliceosome|RNA transport", "Protein": "THO complex subunit 2", "UniProtKB Accession": "B1AZI6"}, {"Human Gene": "MED12", "Mouse Go Name": "NA", "Human Disease Name": "Opitz-Kaveggia syndrome(OKS)|Ohdo syndrome, X-linked(OHDOX)|Lujan-Fryns syndrome(LUJFRYS)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "GAPGPR", "Human UniProtKB Accession": "Q93074", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "A2AGH6-2", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "A2AGH6-2", "Assay Information": [{"GRAVY Score": "-1.12", "CZE Purity": "76.30", "Special Residues": "R+10", "Molecular Weight": "563.3", "AAA Concentration": "56.991000"}], "Gradients": ["NA"], "Transitions": ["NA"], "Unique in protein": "NA", "Peptide Sequence": "GAPGPR", "Concentration Range": ["NA"]}], "Human ProteinName": "Mediator of RNA polymerase II transcription subunit 12", "Human Go Name": "neural tube closure|post-anal tail morphogenesis|Wnt signaling pathway, planar cell polarity pathway|nucleoplasm|vitamin D receptor binding|transcription coactivator activity|intracellular steroid hormone receptor signaling pathway|spinal cord development|positive regulation of transcription, DNA-templated|chromatin binding|transcription coregulator activity|protein domain specific binding|beta-catenin binding|oligodendrocyte development|regulation of transcription by RNA polymerase II|negative regulation of Wnt signaling pathway|membrane|thyroid hormone receptor binding|stem cell population maintenance|heart development|ubiquitin ligase complex|axis elongation involved in somitogenesis|signaling receptor activity|transcription initiation from RNA polymerase II promoter|canonical Wnt signaling pathway|RNA polymerase II distal enhancer sequence-specific DNA binding|protein C-terminus binding|nucleus|embryonic neurocranium morphogenesis|ubiquitin protein ligase activity|positive regulation of transcription by RNA polymerase II|nuclear receptor transcription coactivator activity|mediator complex|embryonic brain development|androgen receptor signaling pathway|endoderm development|Schwann cell development", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "Thyroid hormone signaling pathway", "Biological Matrix Details": [], "Gene": "Med12", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'A2AGH6-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'A2AGH6-2', 'Assay Information': [{'GRAVY Score': '-1.12', 'CZE Purity': '76.30', 'Special Residues': 'R+10', 'Molecular Weight': '563.3', 'AAA Concentration': '56.991000'}], 'Gradients': ['NA'], 'Transitions': ['NA'], 'Unique in protein': 'NA', 'Peptide Sequence': 'GAPGPR', 'Concentration Range': ['NA']}", "SubCellular": "NA", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "Mediator of RNA polymerase II transcription subunit 12", "UniProtKB Accession": "A2AGH6-2"}, {"Human Gene": "OTUD7B", "Mouse Go Name": "negative regulation of transcription by RNA polymerase II|protein K11-linked deubiquitination|adaptive immune response|mucosal immune response|cytoplasm|protein K63-linked deubiquitination|DNA binding|protein K48-linked deubiquitination|thiol-dependent ubiquitinyl hydrolase activity|protein deubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleus|thiol-dependent ubiquitin-specific protease activity|negative regulation of protein localization to nucleus|protein deubiquitination|K63-linked polyubiquitin modification-dependent protein binding|zinc ion binding|cysteine-type peptidase activity|Lys48-specific deubiquitinase activity|negative regulation of interleukin-8 production", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "VADSYSNGYR", "Human UniProtKB Accession": "Q6GQQ9", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "B2RUR8", "Assay Information": [{"GRAVY Score": "-1.01", "CZE Purity": "78.17", "Special Residues": "R+10", "Molecular Weight": "1140.5", "AAA Concentration": "5.900000"}, {"GRAVY Score": "-1.01", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1130.5", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|4|False|566.2569|21|Positive|y9|10|5|2|1032.4381|380|4.0,Agilent6490|1|False|566.2569|17|Positive|y8|10|5|2|961.401|380|1.0,Agilent6490|3|False|566.2569|21|Positive|y7|10|5|2|846.3741|380|3.0,Agilent6490|5|False|566.2569|21|Positive|y6|10|5|2|759.342|380|5.0,Agilent6490|2|False|566.2569|21|Positive|y5|10|5|2|596.2787|380|2.0", "Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|4|True|571.261|21|Positive|y9|10|5|2|1042.4464|380|4.0,Agilent6490|1|True|571.261|17|Positive|y8|10|5|2|971.4093|380|1.0,Agilent6490|3|True|571.261|21|Positive|y7|10|5|2|856.3823|380|3.0,Agilent6490|5|True|571.261|21|Positive|y6|10|5|2|769.3503|380|5.0,Agilent6490|2|True|571.261|21|Positive|y5|10|5|2|606.287|380|2.0"], "Unique in protein": "Yes", "Peptide Sequence": "VADSYSNGYR", "Concentration Range": ["NA"]}], "Human ProteinName": "OTU domain-containing protein 7B", "Human Go Name": "negative regulation of transcription by RNA polymerase II|cysteine-type peptidase activity|adaptive immune response|mucosal immune response|cytosol|cytoplasm|protein K63-linked deubiquitination|DNA binding|negative regulation of protein localization to nucleus|zinc ion binding|protein deubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleus|thiol-dependent ubiquitin-specific protease activity|protein K11-linked deubiquitination|protein deubiquitination|K63-linked polyubiquitin modification-dependent protein binding|negative regulation of interleukin-8 production|thiol-dependent ubiquitinyl hydrolase activity|Lys48-specific deubiquitinase activity|protein K48-linked deubiquitination", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "NA", "Biological Matrix Details": [], "Gene": "Otud7b", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'B2RUR8', 'Assay Information': [{'GRAVY Score': '-1.01', 'CZE Purity': '78.17', 'Special Residues': 'R+10', 'Molecular Weight': '1140.5', 'AAA Concentration': '5.900000'}, {'GRAVY Score': '-1.01', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1130.5', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|4|False|566.2569|21|Positive|y9|10|5|2|1032.4381|380|4.0,Agilent6490|1|False|566.2569|17|Positive|y8|10|5|2|961.401|380|1.0,Agilent6490|3|False|566.2569|21|Positive|y7|10|5|2|846.3741|380|3.0,Agilent6490|5|False|566.2569|21|Positive|y6|10|5|2|759.342|380|5.0,Agilent6490|2|False|566.2569|21|Positive|y5|10|5|2|596.2787|380|2.0', 'Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|4|True|571.261|21|Positive|y9|10|5|2|1042.4464|380|4.0,Agilent6490|1|True|571.261|17|Positive|y8|10|5|2|971.4093|380|1.0,Agilent6490|3|True|571.261|21|Positive|y7|10|5|2|856.3823|380|3.0,Agilent6490|5|True|571.261|21|Positive|y6|10|5|2|769.3503|380|5.0,Agilent6490|2|True|571.261|21|Positive|y5|10|5|2|606.287|380|2.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'VADSYSNGYR', 'Concentration Range': ['NA']}", "SubCellular": "Cytoplasm|Nucleus", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "OTU domain-containing protein 7B", "UniProtKB Accession": "B2RUR8"}, {"Human Gene": "PARK7", "Mouse Go Name": "negative regulation of protein phosphorylation|cytosol|identical protein binding|transcription coactivator activity|positive regulation of mitochondrial electron transport, NADH to ubiquinone|guanine deglycation, methylglyoxal removal|negative regulation of protein K48-linked deubiquitination|positive regulation of androgen receptor activity|tyrosine 3-monooxygenase activator activity|peptidyl-lysine deglycation|DNA repair|regulation of androgen receptor signaling pathway|peptidyl-cysteine deglycation|cellular response to glyoxal|repressing transcription factor binding|positive regulation of oxidative phosphorylation uncoupler activity|glucose homeostasis|positive regulation of pyrroline-5-carboxylate reductase activity|mitochondrion organization|membrane raft|membrane hyperpolarization|enzyme binding|positive regulation of interleukin-8 production|positive regulation of transcription by RNA polymerase II|peroxiredoxin activity|signaling receptor binding|negative regulation of oxidative stress-induced cell death|guanine deglycation|neuron projection|RNA binding|negative regulation of TRAIL-activated apoptotic signaling pathway|autophagy|peptidyl-arginine deglycation|cell body|response to oxidative stress|negative regulation of hydrogen peroxide-induced cell death|negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway|negative regulation of ubiquitin-specific protease activity|negative regulation of apoptotic process|protein deglycosylation|regulation of neuron apoptotic process|dopamine uptake involved in synaptic transmission|scaffold protein binding|positive regulation of tyrosine 3-monooxygenase activity|L-dopa decarboxylase activator activity|synaptic transmission, dopaminergic|positive regulation of NAD(P)H oxidase activity|cellular response to reactive oxygen species|insulin secretion|ubiquitin-specific protease binding|negative regulation of ubiquitin-protein transferase activity|negative regulation of protein ubiquitination|transcription factor binding|negative regulation of protein export from nucleus|inflammatory response|response to hydrogen peroxide|cell proliferation|positive regulation of reactive oxygen species biosynthetic process|perinuclear region of cytoplasm|glutathione deglycation|mitochondrial intermembrane space|protein homodimerization activity|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|axon|positive regulation of L-dopa biosynthetic process|negative regulation of protein kinase activity|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|kinase binding|plasma membrane|PML body|positive regulation of L-dopa decarboxylase activity|cupric ion binding|peptidase activity|endoplasmic reticulum|oxidoreductase activity, acting on peroxide as acceptor|copper ion binding|single fertilization|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|cellular response to oxidative stress|protein deglycase activity|positive regulation of fertilization|protein stabilization|negative regulation of hydrogen peroxide-induced neuron death|positive regulation of dopamine biosynthetic process|membrane depolarization|positive regulation of protein localization to nucleus|hydrogen peroxide metabolic process|superoxide dismutase copper chaperone activity|androgen receptor binding|mRNA binding|positive regulation of gene expression|lactate biosynthetic process|negative regulation of cell death|presynapse|protein deglycation, glyoxal removal|glycolate biosynthetic process|negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway|negative regulation of neuron death|enzyme active site formation via L-cysteine sulfinic acid|negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway|cytoplasm|chromatin|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|adult locomotory behavior|positive regulation of superoxide dismutase activity|glyoxal metabolic process|positive regulation of acute inflammatory response to antigenic stimulus|mitochondrion|positive regulation of transcription regulatory region DNA binding|negative regulation of NMDA glutamate receptor activity|guanine deglycation, glyoxal removal|ubiquitin-like protein conjugating enzyme binding|negative regulation of protein catabolic process|regulation of inflammatory response|cytokine binding|negative regulation of protein sumoylation|mitochondrial respiratory chain complex I|sperm head|negative regulation of protein acetylation|cuprous ion binding|negative regulation of protein binding|regulation of mitochondrial membrane potential|nucleus|detoxification of mercury ion|positive regulation of protein homodimerization activity|cellular response to hydrogen peroxide|negative regulation of oxidative stress-induced neuron death|negative regulation of reactive oxygen species biosynthetic process|positive regulation of peptidyl-serine phosphorylation|detoxification of copper ion|mercury ion binding|mitochondrial matrix|negative regulation of gene expression|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of neuron apoptotic process|positive regulation of DNA-binding transcription factor activity|small protein activating enzyme binding", "Human Disease Name": "Parkinson disease 7(PARK7)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "VTVAGLAGK<br>ALVILAK", "Human UniProtKB Accession": "Q99497", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:1358.4 (fmol/\u00b5g Heart)<br/>Mouse Heart", "UniProtKB Accession": "Q99LX0", "Assay Information": [{"GRAVY Score": "1.16", "CZE Purity": "100.00", "Special Residues": "K+8", "Molecular Weight": "822.49", "AAA Concentration": "7.000000"}], "Gradients": ["Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|412.2606|5|Positive|b2|10|5|2|201.1234|380|72601.0,Agilent6490|2|True|412.2606|9|Positive|y7|10|5|2|623.3966|380|11023.0,Agilent6490|3|True|412.2606|13|Positive|y6|10|5|2|524.3282|380|6444.0,Agilent6490|4|True|412.2606|21|Positive|y3|10|5|2|283.1856|380|5639.0,Agilent6490|5|True|412.2606|21|Positive|y2|10|5|2|212.1485|380|3977.0,Agilent6490|1|False|408.25|5|Positive|b2|10|5|2|201.1234|380|72601.0,Agilent6490|2|False|408.25|9|Positive|y7|10|5|2|615.38|380|11023.0,Agilent6490|3|False|408.25|13|Positive|y6|10|5|2|516.31|380|6444.0,Agilent6490|4|False|408.25|21|Positive|y3|10|5|2|275.17|380|5639.0,Agilent6490|5|False|408.25|21|Positive|y2|10|5|2|204.13|380|3977.0"], "Unique in protein": "Yes", "Peptide Sequence": "VTVAGLAGK", "Concentration Range": ["1358.4 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;3209.28 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "Q99LX0", "Assay Information": [{"GRAVY Score": "2.29", "CZE Purity": "100.00", "Special Residues": "K+8", "Molecular Weight": "734.5", "AAA Concentration": "2.000000"}], "Gradients": ["Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 9,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|2.7|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.8|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|2.7|0.4;Gradient 8,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.77|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 12,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.77|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 13,column: Agilent AdvanceBio Peptide Map  2.1 x 150mm  2.7um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|368.2651|9|Positive|y5|10|5|2|551.4007|380|36078.0,Agilent6490|2|True|368.2651|9|Positive|y4|10|5|2|452.3322|380|10351.0,Agilent6490|3|True|368.2651|13|Positive|y3|10|5|2|339.2482|380|9933.0,Agilent6490|4|True|368.2651|9|Positive|y6|10|5|2|664.4847|380|2338.0,Agilent6490|5|True|368.2651|9|Positive|b3|10|5|2|284.1969|380|2039.0,Agilent6490|1|False|364.257|9|Positive|y5|10|5|2|543.39|380|36078.0,Agilent6490|2|False|364.257|9|Positive|y4|10|5|2|444.32|380|10351.0,Agilent6490|3|False|364.257|13|Positive|y3|10|5|2|331.23|380|9933.0,Agilent6490|4|False|364.257|9|Positive|y6|10|5|2|656.47|380|2338.0,Agilent6490|5|False|364.257|9|Positive|b3|10|5|2|284.2|380|2039.0"], "Unique in protein": "Yes", "Peptide Sequence": "ALVILAK", "Concentration Range": ["NA"]}], "Human ProteinName": "Protein/nucleic acid deglycase DJ-1", "Human Go Name": "glutathione deglycation|cytosol|identical protein binding|positive regulation of androgen receptor activity|positive regulation of mitochondrial electron transport, NADH to ubiquinone|guanine deglycation, methylglyoxal removal|negative regulation of protein K48-linked deubiquitination|tyrosine 3-monooxygenase activator activity|negative regulation of death-inducing signaling complex assembly|peptidyl-lysine deglycation|DNA repair|regulation of androgen receptor signaling pathway|peptidyl-cysteine deglycation|chromatin|repressing transcription factor binding|positive regulation of oxidative phosphorylation uncoupler activity|glucose homeostasis|positive regulation of pyrroline-5-carboxylate reductase activity|mitochondrion organization|membrane raft|membrane hyperpolarization|enzyme binding|positive regulation of interleukin-8 production|presynapse|peroxiredoxin activity|Ras protein signal transduction|signaling receptor binding|negative regulation of oxidative stress-induced cell death|guanine deglycation|nucleoplasm|regulation of supramolecular fiber organization|negative regulation of TRAIL-activated apoptotic signaling pathway|autophagy|peptidyl-arginine deglycation|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|kinase binding|negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway|negative regulation of ubiquitin-specific protease activity|negative regulation of apoptotic process|protein deglycosylation|regulation of neuron apoptotic process|negative regulation of protein binding|dopamine uptake involved in synaptic transmission|scaffold protein binding|plasma membrane|L-dopa decarboxylase activator activity|insulin secretion|ubiquitin-specific protease binding|negative regulation of ubiquitin-protein transferase activity|negative regulation of protein ubiquitination|extracellular exosome|transcription factor binding|negative regulation of protein export from nucleus|inflammatory response|positive regulation of reactive oxygen species biosynthetic process|nucleus|negative regulation of protein phosphorylation|mitochondrial intermembrane space|protein homodimerization activity|positive regulation of autophagy of mitochondrion|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|activation of protein kinase B activity|axon|positive regulation of L-dopa biosynthetic process|negative regulation of protein kinase activity|cell body|negative regulation of hydrogen peroxide-induced cell death|positive regulation of tyrosine 3-monooxygenase activity|PML body|positive regulation of L-dopa decarboxylase activity|cupric ion binding|peptidase activity|positive regulation of protein kinase B signaling|endoplasmic reticulum|oxidoreductase activity, acting on peroxide as acceptor|copper ion binding|single fertilization|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|cellular response to oxidative stress|cytoplasm|protein stabilization|negative regulation of hydrogen peroxide-induced neuron death|positive regulation of dopamine biosynthetic process|cell-cell adherens junction|membrane depolarization|positive regulation of protein localization to nucleus|detoxification of copper ion|cadherin binding|hydrogen peroxide metabolic process|superoxide dismutase copper chaperone activity|androgen receptor binding|mRNA binding|positive regulation of gene expression|lactate biosynthetic process|negative regulation of cell death|positive regulation of transcription by RNA polymerase II|protein deglycation, glyoxal removal|glycolate biosynthetic process|negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway|negative regulation of neuron death|enzyme active site formation via L-cysteine sulfinic acid|negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway|protein deglycation, methylglyoxal removal|protein deglycase activity|cellular response to glyoxal|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|adult locomotory behavior|mitochondrion|glyoxal metabolic process|positive regulation of acute inflammatory response to antigenic stimulus|positive regulation of superoxide dismutase activity|positive regulation of transcription regulatory region DNA binding|guanine deglycation, glyoxal removal|ubiquitin-like protein conjugating enzyme binding|regulation of inflammatory response|cytokine binding|negative regulation of protein sumoylation|negative regulation of protein acetylation|cuprous ion binding|positive regulation of NAD(P)H oxidase activity|regulation of mitochondrial membrane potential|perinuclear region of cytoplasm|detoxification of mercury ion|positive regulation of protein homodimerization activity|cellular response to hydrogen peroxide|methylglyoxal metabolic process|negative regulation of reactive oxygen species biosynthetic process|positive regulation of peptidyl-serine phosphorylation|transcription coactivator activity|mercury ion binding|mitochondrial matrix|negative regulation of gene expression|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of neuron apoptotic process|positive regulation of DNA-binding transcription factor activity|small protein activating enzyme binding", "Human Drug Bank": "NA", "Biological Matrix": "Mouse Brain<br/>Mouse Heart", "Human Kegg Pathway Name": "Parkinson disease", "Biological Matrix Details": [["1358.4 (fmol/\u00b5g Heart)", "Female", "VTVAGLAGK", "Q99LX0", "Mouse Heart"]], "Gene": "Park7", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:1358.4 (fmol/\\xc2\\xb5g Heart)<br/>Mouse Heart', 'UniProtKB Accession': 'Q99LX0', 'Assay Information': [{'GRAVY Score': '1.16', 'CZE Purity': '100.00', 'Special Residues': 'K+8', 'Molecular Weight': '822.49', 'AAA Concentration': '7.000000'}], 'Gradients': ['Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|412.2606|5|Positive|b2|10|5|2|201.1234|380|72601.0,Agilent6490|2|True|412.2606|9|Positive|y7|10|5|2|623.3966|380|11023.0,Agilent6490|3|True|412.2606|13|Positive|y6|10|5|2|524.3282|380|6444.0,Agilent6490|4|True|412.2606|21|Positive|y3|10|5|2|283.1856|380|5639.0,Agilent6490|5|True|412.2606|21|Positive|y2|10|5|2|212.1485|380|3977.0,Agilent6490|1|False|408.25|5|Positive|b2|10|5|2|201.1234|380|72601.0,Agilent6490|2|False|408.25|9|Positive|y7|10|5|2|615.38|380|11023.0,Agilent6490|3|False|408.25|13|Positive|y6|10|5|2|516.31|380|6444.0,Agilent6490|4|False|408.25|21|Positive|y3|10|5|2|275.17|380|5639.0,Agilent6490|5|False|408.25|21|Positive|y2|10|5|2|204.13|380|3977.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'VTVAGLAGK', 'Concentration Range': ['1358.4 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;3209.28 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'Q99LX0', 'Assay Information': [{'GRAVY Score': '2.29', 'CZE Purity': '100.00', 'Special Residues': 'K+8', 'Molecular Weight': '734.5', 'AAA Concentration': '2.000000'}], 'Gradients': ['Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 9,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|2.7|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.8|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|2.7|0.4;Gradient 8,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.77|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 12,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.77|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 13,column: Agilent AdvanceBio Peptide Map  2.1 x 150mm  2.7um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|368.2651|9|Positive|y5|10|5|2|551.4007|380|36078.0,Agilent6490|2|True|368.2651|9|Positive|y4|10|5|2|452.3322|380|10351.0,Agilent6490|3|True|368.2651|13|Positive|y3|10|5|2|339.2482|380|9933.0,Agilent6490|4|True|368.2651|9|Positive|y6|10|5|2|664.4847|380|2338.0,Agilent6490|5|True|368.2651|9|Positive|b3|10|5|2|284.1969|380|2039.0,Agilent6490|1|False|364.257|9|Positive|y5|10|5|2|543.39|380|36078.0,Agilent6490|2|False|364.257|9|Positive|y4|10|5|2|444.32|380|10351.0,Agilent6490|3|False|364.257|13|Positive|y3|10|5|2|331.23|380|9933.0,Agilent6490|4|False|364.257|9|Positive|y6|10|5|2|656.47|380|2338.0,Agilent6490|5|False|364.257|9|Positive|b3|10|5|2|284.2|380|2039.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'ALVILAK', 'Concentration Range': ['NA']}", "SubCellular": "Mitochondrion|Cytoplasm|Nucleus|Membrane raft|Cell membrane", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Parkinson disease", "Protein": "Protein/nucleic acid deglycase DJ-1", "UniProtKB Accession": "Q99LX0"}, {"Human Gene": "TTN", "Mouse Go Name": "detection of muscle stretch|structural constituent of cytoskeleton|muscle myosin complex|protease binding|cardiac muscle contraction|structural constituent of muscle|regulation of relaxation of cardiac muscle|identical protein binding|I band|positive regulation of protein secretion|protein tyrosine kinase activity|in utero embryonic development|somitogenesis|ankyrin binding|heart growth|calcium ion binding|response to calcium ion|positive regulation of gene expression|adult heart development|sarcomere organization|protein self-association|cardiac myofibril assembly|cardiac muscle tissue morphogenesis|calmodulin binding|ATP binding|regulation of catalytic activity|heart development|Z disc|actin filament binding|skeletal muscle thin filament assembly|M band|protein kinase A signaling|striated muscle thin filament|forward locomotion|cardiac muscle fiber development|ventricular system development|sarcomere|skeletal muscle myosin thick filament assembly|telethonin binding|myofibril|enzyme binding|actinin binding|protein kinase binding|muscle contraction|A band|regulation of protein kinase activity|condensed nuclear chromosome|heart morphogenesis|sarcomerogenesis|cardiac muscle hypertrophy|muscle alpha-actinin binding|striated muscle cell development|protein serine/threonine kinase activity", "Human Disease Name": "Cardiomyopathy, familial hypertrophic 9(CMH9)|Cardiomyopathy, dilated 1G(CMD1G)|Hereditary myopathy with early respiratory failure(HMERF)|Limb-girdle muscular dystrophy 2J(LGMD2J)|Tardive tibial muscular dystrophy(TMD)|Salih myopathy(SALMY)", "Organism ID": "10090", "sel": "", "Peptide Sequence": "VLDSPSAPVNLTIR", "Human UniProtKB Accession": "Q8WZ42", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "A2ASS6-2", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "A2ASS6", "Assay Information": [{"GRAVY Score": "0.38", "CZE Purity": "96.70", "Special Residues": "R+10", "Molecular Weight": "1490.82", "AAA Concentration": "7.330000"}], "Gradients": ["Gradient 1,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|3.00|0.4, 1.50|7.00|0.4, 16.00|15.00|0.4, 18.00|15.30|0.4, 33.00|25.00|0.4, 38.00|45.00|0.4, 39.00|90.00|0.4, 42.90|90.00|0.4, 43.00|3.00|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|746.4244|25|Positive|y10|10|5|2|1077.629|380|55494.0,Agilent6490|2|True|746.4244|25|Positive|y10++|10|5|2|539.3182|380|50944.0,Agilent6490|3|True|746.4244|29|Positive|y7|10|5|2|822.5071|380|46554.0,Agilent6490|4|True|746.4244|25|Positive|b2|10|5|2|213.1598|380|37269.0,Agilent6490|5|True|746.4244|21|Positive|b4|10|5|2|415.2187|380|24926.0,Agilent6490|1|False|741.42|25|Positive|y10|10|5|2|1067.62|380|55494.0,Agilent6490|2|False|741.42|25|Positive|y10++|10|5|2|534.31|380|50944.0,Agilent6490|3|False|741.42|29|Positive|y7|10|5|2|812.5|380|46554.0,Agilent6490|4|False|741.42|25|Positive|b2|10|5|2|213.1598|380|37269.0,Agilent6490|5|False|741.42|21|Positive|b4|10|5|2|415.2187|380|24926.0;Instrument|Rank|Heavy|Q1|Q3|CollisionEnergy|DeclusteringPotential|FragmentIon|ParentChargeState|Time|CellExitPotential|Abundance,Qtrap4000|1|True|746.4|1077.6|35|82|y10|2|20|21|0.0,Qtrap4000|2|True|746.4|822.5|41|82|y7|2|20|21|0.0,Qtrap4000|3|True|746.4|213.2|41|82|b2|2|20|21|0.0,Qtrap4000|4|True|746.4|539.3|34|82|y++10|2|20|21|0.0,Qtrap4000|5|True|746.4|415.2|34|82|b4|2|20|21|0.0,Qtrap4000|1|False|741.4|1067.6|35|82|y10|2|20|21|0.0,Qtrap4000|2|False|741.4|812.5|41|82|y7|2|20|21|0.0,Qtrap4000|3|False|741.4|213.2|41|82|b2|2|20|21|0.0,Qtrap4000|4|False|741.4|534.3|34|82|y++10|2|20|21|0.0,Qtrap4000|5|False|741.4|415.2|34|82|b4|2|20|21|0.0"], "Unique in protein": "Yes", "Peptide Sequence": "VLDSPSAPVNLTIR", "Concentration Range": ["NA"]}], "Human ProteinName": "Titin", "Human Go Name": "detection of muscle stretch|condensed nuclear chromosome|protease binding|cytosol|cardiac muscle contraction|structural constituent of muscle|identical protein binding|I band|positive regulation of protein secretion|protein tyrosine kinase activity|platelet degranulation|striated muscle contraction|calcium ion binding|extracellular region|protein self-association|cardiac myofibril assembly|cardiac muscle hypertrophy|cardiac muscle tissue morphogenesis|response to calcium ion|ATP binding|regulation of catalytic activity|Z disc|actin filament binding|skeletal muscle thin filament assembly|M band|protein kinase A signaling|striated muscle thin filament|cardiac muscle fiber development|calmodulin binding|sarcomere|actinin binding|positive regulation of gene expression|sarcomere organization|extracellular exosome|enzyme binding|skeletal muscle myosin thick filament assembly|protein kinase binding|muscle contraction|regulation of protein kinase activity|mitotic chromosome condensation|structural molecule activity conferring elasticity|sarcomerogenesis|telethonin binding|muscle alpha-actinin binding|muscle filament sliding|protein serine/threonine kinase activity", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "Hypertrophic cardiomyopathy (HCM)|Dilated cardiomyopathy (DCM)", "Biological Matrix Details": [], "Gene": "Ttn", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'A2ASS6-2', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'A2ASS6', 'Assay Information': [{'GRAVY Score': '0.38', 'CZE Purity': '96.70', 'Special Residues': 'R+10', 'Molecular Weight': '1490.82', 'AAA Concentration': '7.330000'}], 'Gradients': ['Gradient 1,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|3.00|0.4, 1.50|7.00|0.4, 16.00|15.00|0.4, 18.00|15.30|0.4, 33.00|25.00|0.4, 38.00|45.00|0.4, 39.00|90.00|0.4, 42.90|90.00|0.4, 43.00|3.00|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|746.4244|25|Positive|y10|10|5|2|1077.629|380|55494.0,Agilent6490|2|True|746.4244|25|Positive|y10++|10|5|2|539.3182|380|50944.0,Agilent6490|3|True|746.4244|29|Positive|y7|10|5|2|822.5071|380|46554.0,Agilent6490|4|True|746.4244|25|Positive|b2|10|5|2|213.1598|380|37269.0,Agilent6490|5|True|746.4244|21|Positive|b4|10|5|2|415.2187|380|24926.0,Agilent6490|1|False|741.42|25|Positive|y10|10|5|2|1067.62|380|55494.0,Agilent6490|2|False|741.42|25|Positive|y10++|10|5|2|534.31|380|50944.0,Agilent6490|3|False|741.42|29|Positive|y7|10|5|2|812.5|380|46554.0,Agilent6490|4|False|741.42|25|Positive|b2|10|5|2|213.1598|380|37269.0,Agilent6490|5|False|741.42|21|Positive|b4|10|5|2|415.2187|380|24926.0;Instrument|Rank|Heavy|Q1|Q3|CollisionEnergy|DeclusteringPotential|FragmentIon|ParentChargeState|Time|CellExitPotential|Abundance,Qtrap4000|1|True|746.4|1077.6|35|82|y10|2|20|21|0.0,Qtrap4000|2|True|746.4|822.5|41|82|y7|2|20|21|0.0,Qtrap4000|3|True|746.4|213.2|41|82|b2|2|20|21|0.0,Qtrap4000|4|True|746.4|539.3|34|82|y++10|2|20|21|0.0,Qtrap4000|5|True|746.4|415.2|34|82|b4|2|20|21|0.0,Qtrap4000|1|False|741.4|1067.6|35|82|y10|2|20|21|0.0,Qtrap4000|2|False|741.4|812.5|41|82|y7|2|20|21|0.0,Qtrap4000|3|False|741.4|213.2|41|82|b2|2|20|21|0.0,Qtrap4000|4|False|741.4|534.3|34|82|y++10|2|20|21|0.0,Qtrap4000|5|False|741.4|415.2|34|82|b4|2|20|21|0.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'VLDSPSAPVNLTIR', 'Concentration Range': ['NA']}", "SubCellular": "Cytoplasm|Nucleus", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "Titin", "UniProtKB Accession": "A2ASS6"}, {"Human Gene": "HSP90AA1", "Mouse Go Name": "positive regulation of nitric oxide biosynthetic process|neuron projection|positive regulation of protein polymerization|positive regulation of protein import into nucleus, translocation|protein homodimerization activity|GTPase binding|cytosol|cytoplasm|apical plasma membrane|UTP binding|protein import into mitochondrial outer membrane|dATP binding|response to cold|protein tyrosine kinase activity|regulation of protein ubiquitination|brush border membrane|cellular response to heat|positive regulation of cytotoxic T cell differentiation|cell surface|positive regulation of tau-protein kinase activity|positive regulation of lamellipodium assembly|ubiquitin protein ligase binding|plasma membrane|axonal growth cone|telomerase holoenzyme complex assembly|sperm mitochondrial sheath|disordered domain specific binding|telomere maintenance via telomerase|melanosome|collagen-containing extracellular matrix|cardiac muscle cell apoptotic process|positive regulation of cardiac muscle contraction|positive regulation of protein phosphorylation|positive regulation of protein kinase B signaling|dendritic growth cone|response to salt stress|myelin sheath|TPR domain binding|scaffold protein binding|ATP binding|protein tyrosine kinase binding|positive regulation of cell size|protein phosphatase binding|unfolded protein binding|ATPase activity|positive regulation of telomerase activity|ion channel binding|sperm plasma membrane|histone deacetylase binding|nitric-oxide synthase regulator activity|regulation of cellular protein localization|nitric oxide biosynthetic process|sulfonylurea receptor binding|establishment of cell polarity|response to heat|neuronal cell body|DNA polymerase binding|protein refolding|sperm flagellum|perinuclear region of cytoplasm|identical protein binding|GTP binding|mRNA binding|axon extension|protein stabilization|chaperone-mediated protein complex assembly|protein-containing complex|protein kinase binding|neuron migration|CTP binding|response to antibiotic|response to estrogen|positive regulation of cellular protein catabolic process|Rho GDP-dissociation inhibitor binding|response to unfolded protein|skeletal muscle contraction|basolateral plasma membrane|nucleus|central nervous system neuron axonogenesis|response to cocaine|tau protein binding|positive regulation of peptidyl-serine phosphorylation", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "HSQFIGYPITLFVEK<br>HLEINPDHSIIETLR", "Human UniProtKB Accession": "P07900", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:11099.2 (fmol/\u00b5g Heart)<br/>Mouse Heart", "UniProtKB Accession": "P07901", "Assay Information": [{"GRAVY Score": "0.25", "CZE Purity": "75.00", "Special Residues": "K+8", "Molecular Weight": "1785.94", "AAA Concentration": "9.000000"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|596.326|9|Positive|y8++|10|5|3|477.7911|380|9032.0,Agilent6490|2|True|596.326|9|Positive|y8|10|5|3|954.575|380|3491.0,Agilent6490|3|True|596.326|13|Positive|b6|10|5|3|670.3307|380|3481.0,Agilent6490|4|True|596.326|9|Positive|b7|10|5|3|833.3941|380|2291.0,Agilent6490|5|True|596.326|13|Positive|y6|10|5|3|744.4382|380|2207.0,Agilent6490|1|False|593.654|9|Positive|y8++|10|5|3|473.78|380|9032.0,Agilent6490|2|False|593.654|9|Positive|y8|10|5|3|946.56|380|3491.0,Agilent6490|3|False|593.654|13|Positive|b6|10|5|3|670.3307|380|3481.0,Agilent6490|4|False|593.654|9|Positive|b7|10|5|3|833.3941|380|2291.0,Agilent6490|5|False|593.654|13|Positive|y6|10|5|3|736.42|380|2207.0"], "Unique in protein": "Yes", "Peptide Sequence": "HSQFIGYPITLFVEK", "Concentration Range": ["11099.2 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;165394.6 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P07901", "Assay Information": [{"GRAVY Score": "-0.46", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1785.94", "AAA Concentration": "NA"}, {"GRAVY Score": "-0.46", "CZE Purity": "31.62", "Special Residues": "R+10", "Molecular Weight": "1795.94", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|449.9942|9|Positive|y10++|10|5|4|595.8238|380|65224.0,Agilent6490|2|True|449.9942|9|Positive|b10++|10|5|4|578.7909|380|39950.0,Agilent6490|3|True|449.9942|13|Positive|y4|10|5|4|528.3016|380|36886.0,Agilent6490|4|True|449.9942|13|Positive|y3|10|5|4|399.259|380|34819.0,Agilent6490|5|True|449.9942|25|Positive|b2|10|5|4|251.1503|380|32672.0,Agilent6490|1|False|447.4942|9|Positive|y10++|10|5|4|590.8238|380|65224.0,Agilent6490|2|False|447.4942|9|Positive|b10++|10|5|4|578.7909|380|39950.0,Agilent6490|3|False|447.4942|13|Positive|y4|10|5|4|518.3016|380|36886.0,Agilent6490|4|False|447.4942|13|Positive|y3|10|5|4|389.259|380|34819.0,Agilent6490|5|False|447.4942|25|Positive|b2|10|5|4|251.1503|380|32672.0"], "Unique in protein": "Yes", "Peptide Sequence": "HLEINPDHSIIETLR", "Concentration Range": ["NA"]}], "Human ProteinName": "Heat shock protein HSP 90-alpha", "Human Go Name": "positive regulation of nitric oxide biosynthetic process|GTPase binding|positive regulation of protein polymerization|regulation of protein ubiquitination|protein homodimerization activity|cytosol|cytoplasm|Fc-gamma receptor signaling pathway involved in phagocytosis|identical protein binding|response to cold|regulation of cellular response to heat|MHC class II protein complex binding|cellular response to heat|cell surface|positive regulation of tau-protein kinase activity|nucleotide binding|protein tyrosine kinase binding|plasma membrane|axonal growth cone|lysosomal lumen|response to unfolded protein|protein-containing complex|melanosome|ficolin-1-rich granule lumen|DNA polymerase binding|extracellular region|TPR domain binding|protein unfolding|positive regulation of protein kinase B signaling|dendritic growth cone|ERBB2 signaling pathway|nucleoplasm|myelin sheath|ubiquitin protein ligase binding|scaffold protein binding|ATP binding|signal transduction|RNA binding|protein stabilization|perinuclear region of cytoplasm|ciliary basal body-plasma membrane docking|regulation of protein complex assembly|unfolded protein binding|ATPase activity|positive regulation of telomerase activity|chaperone-mediated autophagy|endocytic vesicle lumen|histone deacetylase binding|cytokine-mediated signaling pathway|regulation of cellular protein localization|membrane|mitochondrial transport|disordered domain specific binding|establishment of cell polarity|protein import into mitochondrial outer membrane|neuronal cell body|G2/M transition of mitotic cell cycle|telomere maintenance via telomerase|positive regulation of peptidyl-serine phosphorylation|nitric-oxide synthase regulator activity|neutrophil degranulation|positive regulation of protein phosphorylation|telomerase holoenzyme complex assembly|axon extension|regulation of G2/M transition of mitotic cell cycle|extracellular exosome|receptor-mediated endocytosis|chaperone-mediated protein complex assembly|secretory granule lumen|regulation of nitric-oxide synthase activity|protein refolding|vascular endothelial growth factor receptor signaling pathway|response to antibiotic|response to heat|protein tyrosine kinase activity|positive regulation of cellular protein catabolic process|ATPase activity, coupled|nucleus|central nervous system neuron axonogenesis|tau protein binding|cofactor metabolic process", "Human Drug Bank": "<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB07325\">N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB03809\">9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB00716\">Nedocromil</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB07317\">(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB02424\">Geldanamycin</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB05134\">CNF1010</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB00615\">Rifabutin</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB03899\">9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB03080\">17-Dmag</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB08786\">4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB06070\">SNX-5422</a>", "Biological Matrix": "Mouse Brain<br/>Mouse Heart", "Human Kegg Pathway Name": "NOD-like receptor signaling pathway|Prostate cancer|Fluid shear stress and atherosclerosis|Estrogen signaling pathway|Antigen processing and presentation|PI3K-Akt signaling pathway|IL-17 signaling pathway|Necroptosis|Th17 cell differentiation|Protein processing in endoplasmic reticulum|Pathways in cancer|Progesterone-mediated oocyte maturation", "Biological Matrix Details": [["11099.2 (fmol/\u00b5g Heart)", "Female", "HSQFIGYPITLFVEK", "P07901", "Mouse Heart"]], "Gene": "Hsp90aa1", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:11099.2 (fmol/\\xc2\\xb5g Heart)<br/>Mouse Heart', 'UniProtKB Accession': 'P07901', 'Assay Information': [{'GRAVY Score': '0.25', 'CZE Purity': '75.00', 'Special Residues': 'K+8', 'Molecular Weight': '1785.94', 'AAA Concentration': '9.000000'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|596.326|9|Positive|y8++|10|5|3|477.7911|380|9032.0,Agilent6490|2|True|596.326|9|Positive|y8|10|5|3|954.575|380|3491.0,Agilent6490|3|True|596.326|13|Positive|b6|10|5|3|670.3307|380|3481.0,Agilent6490|4|True|596.326|9|Positive|b7|10|5|3|833.3941|380|2291.0,Agilent6490|5|True|596.326|13|Positive|y6|10|5|3|744.4382|380|2207.0,Agilent6490|1|False|593.654|9|Positive|y8++|10|5|3|473.78|380|9032.0,Agilent6490|2|False|593.654|9|Positive|y8|10|5|3|946.56|380|3491.0,Agilent6490|3|False|593.654|13|Positive|b6|10|5|3|670.3307|380|3481.0,Agilent6490|4|False|593.654|9|Positive|b7|10|5|3|833.3941|380|2291.0,Agilent6490|5|False|593.654|13|Positive|y6|10|5|3|736.42|380|2207.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'HSQFIGYPITLFVEK', 'Concentration Range': ['11099.2 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;165394.6 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P07901', 'Assay Information': [{'GRAVY Score': '-0.46', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1785.94', 'AAA Concentration': 'NA'}, {'GRAVY Score': '-0.46', 'CZE Purity': '31.62', 'Special Residues': 'R+10', 'Molecular Weight': '1795.94', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|449.9942|9|Positive|y10++|10|5|4|595.8238|380|65224.0,Agilent6490|2|True|449.9942|9|Positive|b10++|10|5|4|578.7909|380|39950.0,Agilent6490|3|True|449.9942|13|Positive|y4|10|5|4|528.3016|380|36886.0,Agilent6490|4|True|449.9942|13|Positive|y3|10|5|4|399.259|380|34819.0,Agilent6490|5|True|449.9942|25|Positive|b2|10|5|4|251.1503|380|32672.0,Agilent6490|1|False|447.4942|9|Positive|y10++|10|5|4|590.8238|380|65224.0,Agilent6490|2|False|447.4942|9|Positive|b10++|10|5|4|578.7909|380|39950.0,Agilent6490|3|False|447.4942|13|Positive|y4|10|5|4|518.3016|380|36886.0,Agilent6490|4|False|447.4942|13|Positive|y3|10|5|4|389.259|380|34819.0,Agilent6490|5|False|447.4942|25|Positive|b2|10|5|4|251.1503|380|32672.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'HLEINPDHSIIETLR', 'Concentration Range': ['NA']}", "SubCellular": "Cytoplasm|Nucleus|Cell membrane|Melanosome", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NOD-like receptor signaling pathway|Prostate cancer|Fluid shear stress and atherosclerosis|Estrogen signaling pathway|Antigen processing and presentation|PI3K-Akt signaling pathway|IL-17 signaling pathway|Necroptosis|Th17 cell differentiation|Protein processing in endoplasmic reticulum|Pathways in cancer|Progesterone-mediated oocyte maturation", "Protein": "Heat shock protein HSP 90-alpha", "UniProtKB Accession": "P07901"}, {"Human Gene": "PTK2B", "Mouse Go Name": "response to osmotic stress|regulation of nitric oxide biosynthetic process|positive regulation of translation|activation of GTPase activity|negative regulation of cell proliferation|response to ethanol|positive regulation of JUN kinase activity|focal adhesion assembly|integrin-mediated signaling pathway|response to calcium ion|positive regulation of peptidyl-tyrosine phosphorylation|NMDA selective glutamate receptor complex|oocyte maturation|glutamatergic synapse|stress fiber assembly|long-term synaptic potentiation|membrane raft|negative regulation of myeloid cell differentiation|enzyme binding|positive regulation of cell migration|positive regulation of angiogenesis|response to glucose|dendritic spine|positive regulation of excitatory postsynaptic potential|regulation of calcium-mediated signaling|positive regulation of nitric-oxide synthase activity|positive regulation of JNK cascade|cellular response to retinoic acid|bone resorption|cellular defense response|negative regulation of apoptotic process|apical dendrite|regulation of macrophage chemotaxis|epidermal growth factor receptor signaling pathway|tumor necrosis factor-mediated signaling pathway|3-phosphoinositide-dependent protein kinase binding|postsynaptic density|regulation of cGMP-mediated signaling|regulation of ubiquitin-dependent protein catabolic process|response to hypoxia|calmodulin-dependent protein kinase activity|marginal zone B cell differentiation|regulation of inositol trisphosphate biosynthetic process|lamellipodium|positive regulation of protein kinase activity|peptidyl-tyrosine autophosphorylation|positive regulation of phosphatidylinositol 3-kinase activity|long-term synaptic depression|nucleus|regulation of cell shape|positive regulation of nitric oxide biosynthetic process|activation of Janus kinase activity|NMDA glutamate receptor activity|response to immobilization stress|cell cortex|axon|negative regulation of bone mineralization|cell body|positive regulation of cell-matrix adhesion|cell projection|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of actin filament polymerization|actin filament organization|negative regulation of ossification|MAPK cascade|positive regulation of reactive oxygen species metabolic process|protein kinase activity|peptidyl-tyrosine phosphorylation|focal adhesion|regulation of cell proliferation|adaptive immune response|positive regulation of DNA biosynthetic process|positive regulation of cellular protein metabolic process|neuronal cell body|positive regulation of cell proliferation|positive regulation of endothelial cell migration|growth cone|positive regulation of B cell chemotaxis|protein phosphorylation|postsynapse|non-membrane spanning protein tyrosine kinase activity|positive regulation of cell growth|response to cocaine|neuron projection development|response to hydrogen peroxide|dendrite|protein tyrosine kinase activity|protein-containing complex binding|cytoskeleton|cellular response to fluid shear stress|glial cell proliferation|cell surface receptor signaling pathway|positive regulation of synaptic transmission, glutamatergic|sprouting angiogenesis|regulation of establishment of cell polarity|regulation of actin cytoskeleton reorganization|positive regulation of neuron projection development|ubiquitin protein ligase binding|ATP binding|negative regulation of potassium ion transport|cell adhesion|negative regulation of muscle cell apoptotic process|chemokine-mediated signaling pathway|regulation of NMDA receptor activity|signal complex assembly|protein C-terminus binding|perinuclear region of cytoplasm|ionotropic glutamate receptor signaling pathway|response to mechanical stimulus|positive regulation of cytosolic calcium ion concentration|angiogenesis|regulation of cell adhesion|response to hormone|extrinsic component of cytoplasmic side of plasma membrane|vascular endothelial growth factor receptor signaling pathway|regulation of release of sequestered calcium ion into cytosol|cell differentiation|response to cAMP|response to lithium ion|negative regulation of neuron apoptotic process|blood vessel endothelial cell migration|positive regulation of ERK1 and ERK2 cascade", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "NLLDAVDQAK<br>EVGLDLFFPK", "Human UniProtKB Accession": "Q14289", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:574.8 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "Q9QVP9", "Assay Information": [{"GRAVY Score": "-0.25", "CZE Purity": "73.80", "Special Residues": "K+8", "Molecular Weight": "1093.57", "AAA Concentration": "10.561000"}, {"GRAVY Score": "-0.25", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1085.57", "AAA Concentration": "NA"}], "Gradients": ["NA", "Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 1,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|3.00|0.4, 1.50|7.00|0.4, 16.00|15.00|0.4, 18.00|15.30|0.4, 33.00|25.00|0.4, 38.00|45.00|0.4, 39.00|90.00|0.4, 42.90|90.00|0.4, 43.00|3.00|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|547.8008|13|Positive|y8|10|5|2|867.4662|380|36666.0,Agilent6490|2|True|547.8008|17|Positive|y7|10|5|2|754.3821|380|26555.0,Agilent6490|3|True|547.8008|9|Positive|b3|10|5|2|341.2183|380|17547.0,Agilent6490|4|True|547.8008|29|Positive|y2|10|5|2|226.1641|380|7203.0,Agilent6490|5|True|547.8008|13|Positive|y5|10|5|2|568.3181|380|7065.0,Agilent6490|1|False|543.7931|13|Positive|y8|10|5|2|859.451|380|36666.0,Agilent6490|2|False|543.7931|17|Positive|y7|10|5|2|746.367|380|26555.0,Agilent6490|3|False|543.7931|9|Positive|b3|10|5|2|341.219|380|17547.0,Agilent6490|4|False|543.7931|29|Positive|y2|10|5|2|218.149|380|7203.0,Agilent6490|5|False|543.7931|13|Positive|y5|10|5|2|560.303|380|7065.0"], "Unique in protein": "Yes", "Peptide Sequence": "NLLDAVDQAK", "Concentration Range": ["NA", "574.8 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;223.95 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;4866 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:9909.95 (fmol/\u00b5g Brain)<br/>Mouse Brain", "UniProtKB Accession": "Q9QVP9", "Assay Information": [{"GRAVY Score": "0.45", "CZE Purity": "50.90", "Special Residues": "K+8", "Molecular Weight": "1171.62", "AAA Concentration": "6.247000"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 1,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|3.00|0.4, 1.50|7.00|0.4, 16.00|15.00|0.4, 18.00|15.30|0.4, 33.00|25.00|0.4, 38.00|45.00|0.4, 39.00|90.00|0.4, 42.90|90.00|0.4, 43.00|3.00|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|586.8263|13|Positive|y6|10|5|2|774.4276|380|9832.0,Agilent6490|2|True|586.8263|25|Positive|y2|10|5|2|252.1798|380|8692.0,Agilent6490|3|True|586.8263|17|Positive|y8|10|5|2|944.5331|380|5661.0,Agilent6490|4|True|586.8263|13|Positive|b2|10|5|2|229.1183|380|4192.0,Agilent6490|5|True|586.8263|17|Positive|y3|10|5|2|399.2482|380|3672.0,Agilent6490|1|False|582.8186|13|Positive|y6|10|5|2|766.413|380|9832.0,Agilent6490|2|False|582.8186|25|Positive|y2|10|5|2|244.165|380|8692.0,Agilent6490|3|False|582.8186|17|Positive|y8|10|5|2|936.518|380|5661.0,Agilent6490|4|False|582.8186|13|Positive|b2|10|5|2|229.119|380|4192.0,Agilent6490|5|False|582.8186|17|Positive|y3|10|5|2|391.233|380|3672.0"], "Unique in protein": "Yes", "Peptide Sequence": "EVGLDLFFPK", "Concentration Range": ["9909.95 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}], "Human ProteinName": "Protein-tyrosine kinase 2-beta", "Human Go Name": "cytosol|protein-containing complex assembly|positive regulation of translation|activation of GTPase activity|negative regulation of cell proliferation|response to ethanol|NMDA glutamate receptor activity|focal adhesion assembly|integrin-mediated signaling pathway|response to calcium ion|positive regulation of peptidyl-tyrosine phosphorylation|protein autophosphorylation|NMDA selective glutamate receptor complex|oocyte maturation|interleukin-2-mediated signaling pathway|glutamatergic synapse|stress fiber assembly|long-term synaptic potentiation|membrane raft|negative regulation of myeloid cell differentiation|positive regulation of cell migration|positive regulation of angiogenesis|signal transduction|dendritic spine|positive regulation of excitatory postsynaptic potential|regulation of calcium-mediated signaling|positive regulation of nitric-oxide synthase activity|positive regulation of JNK cascade|cellular response to retinoic acid|bone resorption|cellular defense response|response to hydrogen peroxide|negative regulation of apoptotic process|regulation of synaptic plasticity|apical dendrite|epidermal growth factor receptor signaling pathway|tumor necrosis factor-mediated signaling pathway|3-phosphoinositide-dependent protein kinase binding|postsynaptic density|regulation of cGMP-mediated signaling|regulation of ubiquitin-dependent protein catabolic process|response to hypoxia|calmodulin-dependent protein kinase activity|marginal zone B cell differentiation|regulation of inositol trisphosphate biosynthetic process|lamellipodium|positive regulation of protein kinase activity|peptidyl-tyrosine autophosphorylation|positive regulation of phosphatidylinositol 3-kinase activity|long-term synaptic depression|nucleus|positive regulation of nitric oxide biosynthetic process|activation of Janus kinase activity|positive regulation of JUN kinase activity|response to immobilization stress|cell cortex|negative regulation of bone mineralization|cell body|positive regulation of cell-matrix adhesion|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of actin filament polymerization|regulation of cell shape|MAPK cascade|peptidyl-tyrosine phosphorylation|focal adhesion|regulation of cell proliferation|adaptive immune response|positive regulation of DNA biosynthetic process|neuronal cell body|positive regulation of cell proliferation|positive regulation of endothelial cell migration|growth cone|positive regulation of B cell chemotaxis|response to glucose|non-membrane spanning protein tyrosine kinase activity|positive regulation of cell growth|response to cocaine|protein phosphorylation|neuron projection development|cytoplasm|apoptotic process|dendrite|protein tyrosine kinase activity|protein-containing complex binding|regulation of actin cytoskeleton reorganization|regulation of macrophage chemotaxis|cellular response to fluid shear stress|cytoskeleton|cell surface receptor signaling pathway|positive regulation of synaptic transmission, glutamatergic|sprouting angiogenesis|regulation of establishment of cell polarity|glial cell proliferation|positive regulation of neuron projection development|ubiquitin protein ligase binding|ATP binding|negative regulation of potassium ion transport|negative regulation of muscle cell apoptotic process|chemokine-mediated signaling pathway|regulation of NMDA receptor activity|response to osmotic stress|signal complex assembly|protein C-terminus binding|perinuclear region of cytoplasm|ionotropic glutamate receptor signaling pathway|response to mechanical stimulus|positive regulation of cytosolic calcium ion concentration|blood vessel endothelial cell migration|regulation of cell adhesion|response to hormone|extrinsic component of cytoplasmic side of plasma membrane|vascular endothelial growth factor receptor signaling pathway|regulation of release of sequestered calcium ion into cytosol|cell differentiation|response to cAMP|response to lithium ion|negative regulation of neuron apoptotic process|angiogenesis|positive regulation of ERK1 and ERK2 cascade", "Human Drug Bank": "<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB01645\">Genistein</a>|<a target=\"_blank\" href=\"https://www.drugbank.ca/drugs/DB01097\">Leflunomide</a>", "Biological Matrix": "Mouse Brain<br/>Mouse Lung<br/>Mouse Heart", "Human Kegg Pathway Name": "Leukocyte transendothelial migration|Human immunodeficiency virus 1 infection|Calcium signaling pathway|GnRH signaling pathway|Natural killer cell mediated cytotoxicity|Phospholipase D signaling pathway|Hepatitis B|Chemokine signaling pathway|Human cytomegalovirus infection", "Biological Matrix Details": [["574.8 (fmol/\u00b5g Lung)", "Female", "NLLDAVDQAK", "Q9QVP9", "Mouse Lung"], ["9909.95 (fmol/\u00b5g Brain)", "Female", "EVGLDLFFPK", "Q9QVP9", "Mouse Brain"]], "Gene": "Ptk2b", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:574.8 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'Q9QVP9', 'Assay Information': [{'GRAVY Score': '-0.25', 'CZE Purity': '73.80', 'Special Residues': 'K+8', 'Molecular Weight': '1093.57', 'AAA Concentration': '10.561000'}, {'GRAVY Score': '-0.25', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1085.57', 'AAA Concentration': 'NA'}], 'Gradients': ['NA', 'Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 1,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|3.00|0.4, 1.50|7.00|0.4, 16.00|15.00|0.4, 18.00|15.30|0.4, 33.00|25.00|0.4, 38.00|45.00|0.4, 39.00|90.00|0.4, 42.90|90.00|0.4, 43.00|3.00|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|547.8008|13|Positive|y8|10|5|2|867.4662|380|36666.0,Agilent6490|2|True|547.8008|17|Positive|y7|10|5|2|754.3821|380|26555.0,Agilent6490|3|True|547.8008|9|Positive|b3|10|5|2|341.2183|380|17547.0,Agilent6490|4|True|547.8008|29|Positive|y2|10|5|2|226.1641|380|7203.0,Agilent6490|5|True|547.8008|13|Positive|y5|10|5|2|568.3181|380|7065.0,Agilent6490|1|False|543.7931|13|Positive|y8|10|5|2|859.451|380|36666.0,Agilent6490|2|False|543.7931|17|Positive|y7|10|5|2|746.367|380|26555.0,Agilent6490|3|False|543.7931|9|Positive|b3|10|5|2|341.219|380|17547.0,Agilent6490|4|False|543.7931|29|Positive|y2|10|5|2|218.149|380|7203.0,Agilent6490|5|False|543.7931|13|Positive|y5|10|5|2|560.303|380|7065.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'NLLDAVDQAK', 'Concentration Range': ['NA', '574.8 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;223.95 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;4866 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:9909.95 (fmol/\\xc2\\xb5g Brain)<br/>Mouse Brain', 'UniProtKB Accession': 'Q9QVP9', 'Assay Information': [{'GRAVY Score': '0.45', 'CZE Purity': '50.90', 'Special Residues': 'K+8', 'Molecular Weight': '1171.62', 'AAA Concentration': '6.247000'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 1,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|3.00|0.4, 1.50|7.00|0.4, 16.00|15.00|0.4, 18.00|15.30|0.4, 33.00|25.00|0.4, 38.00|45.00|0.4, 39.00|90.00|0.4, 42.90|90.00|0.4, 43.00|3.00|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|586.8263|13|Positive|y6|10|5|2|774.4276|380|9832.0,Agilent6490|2|True|586.8263|25|Positive|y2|10|5|2|252.1798|380|8692.0,Agilent6490|3|True|586.8263|17|Positive|y8|10|5|2|944.5331|380|5661.0,Agilent6490|4|True|586.8263|13|Positive|b2|10|5|2|229.1183|380|4192.0,Agilent6490|5|True|586.8263|17|Positive|y3|10|5|2|399.2482|380|3672.0,Agilent6490|1|False|582.8186|13|Positive|y6|10|5|2|766.413|380|9832.0,Agilent6490|2|False|582.8186|25|Positive|y2|10|5|2|244.165|380|8692.0,Agilent6490|3|False|582.8186|17|Positive|y8|10|5|2|936.518|380|5661.0,Agilent6490|4|False|582.8186|13|Positive|b2|10|5|2|229.119|380|4192.0,Agilent6490|5|False|582.8186|17|Positive|y3|10|5|2|391.233|380|3672.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'EVGLDLFFPK', 'Concentration Range': ['9909.95 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']}", "SubCellular": "Cytoplasm|Nucleus|Cell projection|Cell junction|Cell membrane", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Natural killer cell mediated cytotoxicity|Human immunodeficiency virus 1 infection|GnRH signaling pathway|Calcium signaling pathway|Leukocyte transendothelial migration|Phospholipase D signaling pathway|Hepatitis B|Chemokine signaling pathway|Human cytomegalovirus infection", "Protein": "Protein-tyrosine kinase 2-beta", "UniProtKB Accession": "Q9QVP9"}, {"Human Gene": "PRDX1", "Mouse Go Name": "protein homodimerization activity|cytosol|cytoplasm|identical protein binding|natural killer cell mediated cytotoxicity|peroxisomal matrix|regulation of NIK/NF-kappaB signaling|mitochondrion|regulation of stress-activated MAPK cascade|response to oxidative stress|cell proliferation|myelin sheath|natural killer cell activation|heme binding|peroxidase activity|thioredoxin peroxidase activity|erythrocyte homeostasis|nucleus|response to reactive oxygen species|hydrogen peroxide catabolic process|nucleolus|nuclear euchromatin|removal of superoxide radicals|peroxiredoxin activity|mitochondrial matrix|cell redox homeostasis", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "LVQAFQFTDK<br>ADEGISFR<br>TIAQDYGVLK", "Human UniProtKB Accession": "Q06830", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P35700", "Assay Information": [{"GRAVY Score": "0.03", "CZE Purity": "86.60", "Special Residues": "K+8", "Molecular Weight": "1203.62", "AAA Concentration": "8.000000"}, {"GRAVY Score": "0.03", "CZE Purity": "89.91", "Special Residues": "K+8", "Molecular Weight": "1203.62", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|602.8268|13|Positive|y8++|10|5|2|496.75|380|480266.0,Agilent6490|2|True|602.8268|17|Positive|y8|10|5|2|992.4927|380|387791.0,Agilent6490|3|True|602.8268|13|Positive|b2|10|5|2|213.1598|380|369330.0,Agilent6490|4|True|602.8268|17|Positive|y7|10|5|2|864.4341|380|276237.0,Agilent6490|5|True|602.8268|17|Positive|b3|10|5|2|341.2183|380|170459.0,Agilent6490|1|False|598.8268|13|Positive|y8++|10|5|2|492.75|380|480266.0,Agilent6490|2|False|598.8268|17|Positive|y8|10|5|2|984.4927|380|387791.0,Agilent6490|3|False|598.8268|13|Positive|b2|10|5|2|213.1598|380|369330.0,Agilent6490|4|False|598.8268|17|Positive|y7|10|5|2|856.4341|380|276237.0,Agilent6490|5|False|598.8268|17|Positive|b3|10|5|2|341.2183|380|170459.0", "Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|602.8268|9|Positive|y8++|10|5|2|496.75|380|247131.0,Agilent6490|2|True|602.8268|9|Positive|b2|10|5|2|213.1598|380|190123.0,Agilent6490|3|True|602.8268|13|Positive|y8|10|5|2|992.4927|380|187210.0,Agilent6490|4|True|602.8268|17|Positive|y7|10|5|2|864.4341|380|157663.0,Agilent6490|5|True|602.8268|25|Positive|y4|10|5|2|518.27|380|104912.0,Agilent6490|1|False|598.82|9|Positive|y8++|10|5|2|492.74|380|247131.0,Agilent6490|2|False|598.82|9|Positive|b2|10|5|2|213.1598|380|190123.0,Agilent6490|3|False|598.82|13|Positive|y8|10|5|2|984.48|380|187210.0,Agilent6490|4|False|598.82|17|Positive|y7|10|5|2|856.42|380|157663.0,Agilent6490|5|False|598.82|25|Positive|y4|10|5|2|510.26|380|104912.0"], "Unique in protein": "Yes", "Peptide Sequence": "LVQAFQFTDK", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:4.32E+00(fmol/\u00b5L plasma)<br/>Mouse Plasma", "UniProtKB Accession": "P35700", "Assay Information": [{"GRAVY Score": "-0.45", "CZE Purity": "93.40", "Special Residues": "R+10", "Molecular Weight": "903.42", "AAA Concentration": "9.000000"}, {"GRAVY Score": "-0.45", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "893.42", "AAA Concentration": "NA"}], "Gradients": ["NA", "Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 13,column: Agilent AdvanceBio Peptide Map  2.1 x 150mm  2.7um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|452.7241|13|Positive|y5|10|5|2|589.3332|380|13302.0,Agilent6490|2|True|452.7241|9|Positive|y3|10|5|2|419.2277|380|10735.0,Agilent6490|3|True|452.7241|9|Positive|y6|10|5|2|718.3758|380|9380.0,Agilent6490|4|True|452.7241|17|Positive|y2|10|5|2|332.1956|380|3885.0,Agilent6490|5|True|452.7241|9|Positive|y4|10|5|2|532.3117|380|3529.0,Agilent6490|1|False|447.719|13|Positive|y5|10|5|2|579.32|380|13302.0,Agilent6490|2|False|447.719|9|Positive|y3|10|5|2|409.22|380|10735.0,Agilent6490|3|False|447.719|9|Positive|y6|10|5|2|708.37|380|9380.0,Agilent6490|4|False|447.719|17|Positive|y2|10|5|2|322.19|380|3885.0,Agilent6490|5|False|447.719|9|Positive|y4|10|5|2|522.3|380|3529.0"], "Unique in protein": "Yes", "Peptide Sequence": "ADEGISFR", "Concentration Range": ["NA", "4.32E+00(fmol/\u00b5L plasma)|2.19(fmol/\u00b5L plasma)|9.94(fmol/\u00b5L plasma)|58|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.09(fmol/\u00b5L plasma)|22.52(fmol/\u00b5L plasma)|Female;2.63E+00(fmol/\u00b5L plasma)|0.57(fmol/\u00b5L plasma)|6.25(fmol/\u00b5L plasma)|120|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.07(fmol/\u00b5L plasma)|28.81(fmol/\u00b5L plasma)|Female;2.46E+00(fmol/\u00b5L plasma)|0.9(fmol/\u00b5L plasma)|6.12(fmol/\u00b5L plasma)|32|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.02(fmol/\u00b5L plasma)|21.3(fmol/\u00b5L plasma)|Female;4.81E+00(fmol/\u00b5L plasma)|3.0(fmol/\u00b5L plasma)|7.79(fmol/\u00b5L plasma)|66|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.03(fmol/\u00b5L plasma)|25.89(fmol/\u00b5L plasma)|Female;3.43E+00(fmol/\u00b5L plasma)|2.64(fmol/\u00b5L plasma)|4.22(fmol/\u00b5L plasma)|4|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.05(fmol/\u00b5L plasma)|21.3(fmol/\u00b5L plasma)|Female;17452.52 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:26601.84 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "P35700", "Assay Information": [{"GRAVY Score": "0.10", "CZE Purity": "98.36", "Special Residues": "K+8", "Molecular Weight": "1114.6", "AAA Concentration": "7.000000"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|558.3135|13|Positive|y8|10|5|2|901.4869|380|146457.0,Agilent6490|2|True|558.3135|13|Positive|b2|10|5|2|215.139|380|114671.0,Agilent6490|3|True|558.3135|13|Positive|y6|10|5|2|702.3912|380|26088.0,Agilent6490|4|True|558.3135|13|Positive|y7|10|5|2|830.4498|380|23612.0,Agilent6490|5|True|558.3135|9|Positive|y8++|10|5|2|451.2471|380|23540.0,Agilent6490|1|False|554.31|13|Positive|y8|10|5|2|893.47|380|146457.0,Agilent6490|2|False|554.31|13|Positive|b2|10|5|2|215.139|380|114671.0,Agilent6490|3|False|554.31|13|Positive|y6|10|5|2|694.38|380|26088.0,Agilent6490|4|False|554.31|13|Positive|y7|10|5|2|822.43|380|23612.0,Agilent6490|5|False|554.31|9|Positive|y8++|10|5|2|447.24|380|23540.0"], "Unique in protein": "Yes", "Peptide Sequence": "TIAQDYGVLK", "Concentration Range": ["26601.84 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;17022.88 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;22883.58 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female"]}], "Human ProteinName": "Peroxiredoxin-1", "Human Go Name": "cytosol|cytoplasm|identical protein binding|natural killer cell mediated cytotoxicity|regulation of stress-activated MAPK cascade|response to oxidative stress|extracellular space|melanosome|cell proliferation|myelin sheath|retina homeostasis|natural killer cell activation|cellular response to oxidative stress|RNA binding|skeletal system development|removal of superoxide radicals|thioredoxin peroxidase activity|erythrocyte homeostasis|cadherin binding|nucleus|regulation of NIK/NF-kappaB signaling|extracellular exosome|hydrogen peroxide catabolic process|peroxidase activity|cell redox homeostasis", "Human Drug Bank": "NA", "Biological Matrix": "Mouse Brain<br/>Mouse Lung<br/>Mouse Heart", "Human Kegg Pathway Name": "Peroxisome", "Biological Matrix Details": [["4.32E+00(fmol/\u00b5L plasma)", "Female", "ADEGISFR", "P35700", "Mouse Plasma"], ["26601.84 (fmol/\u00b5g Lung)", "Female", "TIAQDYGVLK", "P35700", "Mouse Lung"], ["17022.88 (fmol/\u00b5g Heart)", "Female", "TIAQDYGVLK", "P35700", "Mouse Heart"], ["22883.58 (fmol/\u00b5g Brain)", "Female", "TIAQDYGVLK", "P35700", "Mouse Brain"]], "Gene": "Prdx1", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P35700', 'Assay Information': [{'GRAVY Score': '0.03', 'CZE Purity': '86.60', 'Special Residues': 'K+8', 'Molecular Weight': '1203.62', 'AAA Concentration': '8.000000'}, {'GRAVY Score': '0.03', 'CZE Purity': '89.91', 'Special Residues': 'K+8', 'Molecular Weight': '1203.62', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|602.8268|13|Positive|y8++|10|5|2|496.75|380|480266.0,Agilent6490|2|True|602.8268|17|Positive|y8|10|5|2|992.4927|380|387791.0,Agilent6490|3|True|602.8268|13|Positive|b2|10|5|2|213.1598|380|369330.0,Agilent6490|4|True|602.8268|17|Positive|y7|10|5|2|864.4341|380|276237.0,Agilent6490|5|True|602.8268|17|Positive|b3|10|5|2|341.2183|380|170459.0,Agilent6490|1|False|598.8268|13|Positive|y8++|10|5|2|492.75|380|480266.0,Agilent6490|2|False|598.8268|17|Positive|y8|10|5|2|984.4927|380|387791.0,Agilent6490|3|False|598.8268|13|Positive|b2|10|5|2|213.1598|380|369330.0,Agilent6490|4|False|598.8268|17|Positive|y7|10|5|2|856.4341|380|276237.0,Agilent6490|5|False|598.8268|17|Positive|b3|10|5|2|341.2183|380|170459.0', 'Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|602.8268|9|Positive|y8++|10|5|2|496.75|380|247131.0,Agilent6490|2|True|602.8268|9|Positive|b2|10|5|2|213.1598|380|190123.0,Agilent6490|3|True|602.8268|13|Positive|y8|10|5|2|992.4927|380|187210.0,Agilent6490|4|True|602.8268|17|Positive|y7|10|5|2|864.4341|380|157663.0,Agilent6490|5|True|602.8268|25|Positive|y4|10|5|2|518.27|380|104912.0,Agilent6490|1|False|598.82|9|Positive|y8++|10|5|2|492.74|380|247131.0,Agilent6490|2|False|598.82|9|Positive|b2|10|5|2|213.1598|380|190123.0,Agilent6490|3|False|598.82|13|Positive|y8|10|5|2|984.48|380|187210.0,Agilent6490|4|False|598.82|17|Positive|y7|10|5|2|856.42|380|157663.0,Agilent6490|5|False|598.82|25|Positive|y4|10|5|2|510.26|380|104912.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'LVQAFQFTDK', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:4.32E+00(fmol/\\xc2\\xb5L plasma)<br/>Mouse Plasma', 'UniProtKB Accession': 'P35700', 'Assay Information': [{'GRAVY Score': '-0.45', 'CZE Purity': '93.40', 'Special Residues': 'R+10', 'Molecular Weight': '903.42', 'AAA Concentration': '9.000000'}, {'GRAVY Score': '-0.45', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '893.42', 'AAA Concentration': 'NA'}], 'Gradients': ['NA', 'Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4;Gradient 4,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4;Gradient 13,column: Agilent AdvanceBio Peptide Map  2.1 x 150mm  2.7um, Time [min] | B [%] | Flow [ml/min], 0.00|2.70|0.4, 1.50|6.30|0.4, 16.00|13.50|0.4, 18.00|13.80|0.4, 33.00|22.50|0.4, 38.00|40.50|0.4, 39.00|81.00|0.4, 42.90|81.00|0.4, 43.00|2.70|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|452.7241|13|Positive|y5|10|5|2|589.3332|380|13302.0,Agilent6490|2|True|452.7241|9|Positive|y3|10|5|2|419.2277|380|10735.0,Agilent6490|3|True|452.7241|9|Positive|y6|10|5|2|718.3758|380|9380.0,Agilent6490|4|True|452.7241|17|Positive|y2|10|5|2|332.1956|380|3885.0,Agilent6490|5|True|452.7241|9|Positive|y4|10|5|2|532.3117|380|3529.0,Agilent6490|1|False|447.719|13|Positive|y5|10|5|2|579.32|380|13302.0,Agilent6490|2|False|447.719|9|Positive|y3|10|5|2|409.22|380|10735.0,Agilent6490|3|False|447.719|9|Positive|y6|10|5|2|708.37|380|9380.0,Agilent6490|4|False|447.719|17|Positive|y2|10|5|2|322.19|380|3885.0,Agilent6490|5|False|447.719|9|Positive|y4|10|5|2|522.3|380|3529.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'ADEGISFR', 'Concentration Range': ['NA', '4.32E+00(fmol/\\xc2\\xb5L plasma)|2.19(fmol/\\xc2\\xb5L plasma)|9.94(fmol/\\xc2\\xb5L plasma)|58|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.09(fmol/\\xc2\\xb5L plasma)|22.52(fmol/\\xc2\\xb5L plasma)|Female;2.63E+00(fmol/\\xc2\\xb5L plasma)|0.57(fmol/\\xc2\\xb5L plasma)|6.25(fmol/\\xc2\\xb5L plasma)|120|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.07(fmol/\\xc2\\xb5L plasma)|28.81(fmol/\\xc2\\xb5L plasma)|Female;2.46E+00(fmol/\\xc2\\xb5L plasma)|0.9(fmol/\\xc2\\xb5L plasma)|6.12(fmol/\\xc2\\xb5L plasma)|32|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.02(fmol/\\xc2\\xb5L plasma)|21.3(fmol/\\xc2\\xb5L plasma)|Female;4.81E+00(fmol/\\xc2\\xb5L plasma)|3.0(fmol/\\xc2\\xb5L plasma)|7.79(fmol/\\xc2\\xb5L plasma)|66|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.03(fmol/\\xc2\\xb5L plasma)|25.89(fmol/\\xc2\\xb5L plasma)|Female;3.43E+00(fmol/\\xc2\\xb5L plasma)|2.64(fmol/\\xc2\\xb5L plasma)|4.22(fmol/\\xc2\\xb5L plasma)|4|Mouse Plasma|Urea-based|Worthington Trypsin|6490|0.05(fmol/\\xc2\\xb5L plasma)|21.3(fmol/\\xc2\\xb5L plasma)|Female;17452.52 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:26601.84 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'P35700', 'Assay Information': [{'GRAVY Score': '0.10', 'CZE Purity': '98.36', 'Special Residues': 'K+8', 'Molecular Weight': '1114.6', 'AAA Concentration': '7.000000'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|558.3135|13|Positive|y8|10|5|2|901.4869|380|146457.0,Agilent6490|2|True|558.3135|13|Positive|b2|10|5|2|215.139|380|114671.0,Agilent6490|3|True|558.3135|13|Positive|y6|10|5|2|702.3912|380|26088.0,Agilent6490|4|True|558.3135|13|Positive|y7|10|5|2|830.4498|380|23612.0,Agilent6490|5|True|558.3135|9|Positive|y8++|10|5|2|451.2471|380|23540.0,Agilent6490|1|False|554.31|13|Positive|y8|10|5|2|893.47|380|146457.0,Agilent6490|2|False|554.31|13|Positive|b2|10|5|2|215.139|380|114671.0,Agilent6490|3|False|554.31|13|Positive|y6|10|5|2|694.38|380|26088.0,Agilent6490|4|False|554.31|13|Positive|y7|10|5|2|822.43|380|23612.0,Agilent6490|5|False|554.31|9|Positive|y8++|10|5|2|447.24|380|23540.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'TIAQDYGVLK', 'Concentration Range': ['26601.84 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;17022.88 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;22883.58 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female']}", "SubCellular": "Cytoplasm", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "Peroxisome", "Protein": "Peroxiredoxin-1", "UniProtKB Accession": "P35700"}, {"Human Gene": "HIST1H2AB", "Mouse Go Name": "nucleosome|negative regulation of transcription by RNA polymerase II|negative regulation of DNA recombination|histone deacetylase binding|regulation of transcription, DNA-templated|establishment of protein localization to chromatin|DNA binding|muscle organ development|negative regulation of chromatin silencing|nucleosome assembly|nucleus|nucleosomal DNA binding|double-stranded DNA binding|nuclear heterochromatin|chromosome condensation|positive regulation of histone H3-K9 methylation|nucleosome positioning", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "ATGPPVSELITK<br>ALAAGGYDVEK<br>GTGASGSFK", "Human UniProtKB Accession": "P04908", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P43276", "Assay Information": [{"GRAVY Score": "0.09", "CZE Purity": "94.21", "Special Residues": "K+8", "Molecular Weight": "1219.68", "AAA Concentration": "NA"}], "Gradients": ["Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|610.853|17|Positive|y9++|10|5|2|496.2993|380|1804128.0,Agilent6490|2|True|610.853|13|Positive|y10++|10|5|2|524.8101|380|1595249.0,Agilent6490|3|True|610.853|17|Positive|y8|10|5|2|894.5386|380|910886.0,Agilent6490|4|True|610.853|17|Positive|y10|10|5|2|1048.6128|380|357409.0,Agilent6490|5|True|610.853|25|Positive|y2|10|5|2|256.1747|380|307075.0,Agilent6490|1|False|606.85|17|Positive|y9++|10|5|2|492.29|380|1804128.0,Agilent6490|2|False|606.85|13|Positive|y10++|10|5|2|520.8|380|1595249.0,Agilent6490|3|False|606.85|17|Positive|y8|10|5|2|886.52|380|910886.0,Agilent6490|4|False|606.85|17|Positive|y10|10|5|2|1040.6|380|357409.0,Agilent6490|5|False|606.85|25|Positive|y2|10|5|2|248.16|380|307075.0"], "Unique in protein": "Yes", "Peptide Sequence": "ATGPPVSELITK", "Concentration Range": ["NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "Mean Conc.:2474.58 (fmol/\u00b5g Lung)<br/>Mouse Lung", "UniProtKB Accession": "P43276", "Assay Information": [{"GRAVY Score": "0.04", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1092.55", "AAA Concentration": "NA"}, {"GRAVY Score": "0.04", "CZE Purity": "68.85", "Special Residues": "K+8", "Molecular Weight": "1100.55", "AAA Concentration": "9.520000"}], "Gradients": ["NA", "Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|551.2875|13|Positive|y9|10|5|2|917.4454|380|62568.0,Agilent6490|2|True|551.2875|17|Positive|y7|10|5|2|775.3712|380|44865.0,Agilent6490|3|True|551.2875|17|Positive|b3|10|5|2|256.1656|380|32368.0,Agilent6490|4|True|551.2875|17|Positive|y8|10|5|2|846.4083|380|29259.0,Agilent6490|5|True|551.2875|9|Positive|y9++|10|5|2|459.2264|380|17130.0,Agilent6490|1|False|547.28|13|Positive|y9|10|5|2|909.43|380|62568.0,Agilent6490|2|False|547.28|17|Positive|y7|10|5|2|767.36|380|44865.0,Agilent6490|3|False|547.28|17|Positive|b3|10|5|2|256.17|380|32368.0,Agilent6490|4|False|547.28|17|Positive|y8|10|5|2|838.39|380|29259.0,Agilent6490|5|False|547.28|9|Positive|y9++|10|5|2|455.22|380|17130.0"], "Unique in protein": "Yes", "Peptide Sequence": "ALAAGGYDVEK", "Concentration Range": ["2474.58 (fmol/\u00b5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1640.74 (fmol/\u00b5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1937.38 (fmol/\u00b5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female", "NA"]}, {"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "P43276", "Assay Information": [{"GRAVY Score": "-0.31", "CZE Purity": "NA", "Special Residues": "K+8", "Molecular Weight": "818.39", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|410.2085|9|Positive|y7|10|5|2|661.3395|380|122608.0,Agilent6490|2|True|410.2085|13|Positive|y5|10|5|2|533.2809|380|47730.0,Agilent6490|3|True|410.2085|17|Positive|y4|10|5|2|446.2489|380|24264.0,Agilent6490|4|True|410.2085|13|Positive|y6|10|5|2|604.3181|380|12936.0,Agilent6490|5|True|410.2085|9|Positive|y8++|10|5|2|381.6972|380|12208.0,Agilent6490|1|False|406.2014|9|Positive|y7|10|5|2|653.3395|380|122608.0,Agilent6490|2|False|406.2014|13|Positive|y5|10|5|2|525.2809|380|47730.0,Agilent6490|3|False|406.2014|17|Positive|y4|10|5|2|438.2489|380|24264.0,Agilent6490|4|False|406.2014|13|Positive|y6|10|5|2|596.3181|380|12936.0,Agilent6490|5|False|406.2014|9|Positive|y8++|10|5|2|377.6972|380|12208.0"], "Unique in protein": "NA", "Peptide Sequence": "GTGASGSFK", "Concentration Range": ["NA"]}], "Human ProteinName": "Histone H2A type 1-B/E", "Human Go Name": "nuclear chromatin|nucleosome|chromatin organization|DNA binding|protein heterodimerization activity|nucleus|negative regulation of cell proliferation|extracellular exosome", "Human Drug Bank": "NA", "Biological Matrix": "Mouse Brain<br/>Mouse Lung<br/>Mouse Heart", "Human Kegg Pathway Name": "Systemic lupus erythematosus|Alcoholism|Necroptosis", "Biological Matrix Details": [["2474.58 (fmol/\u00b5g Lung)", "Female", "ALAAGGYDVEK", "P43276", "Mouse Lung"]], "Gene": "Hist1h1b", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P43276', 'Assay Information': [{'GRAVY Score': '0.09', 'CZE Purity': '94.21', 'Special Residues': 'K+8', 'Molecular Weight': '1219.68', 'AAA Concentration': 'NA'}], 'Gradients': ['Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|610.853|17|Positive|y9++|10|5|2|496.2993|380|1804128.0,Agilent6490|2|True|610.853|13|Positive|y10++|10|5|2|524.8101|380|1595249.0,Agilent6490|3|True|610.853|17|Positive|y8|10|5|2|894.5386|380|910886.0,Agilent6490|4|True|610.853|17|Positive|y10|10|5|2|1048.6128|380|357409.0,Agilent6490|5|True|610.853|25|Positive|y2|10|5|2|256.1747|380|307075.0,Agilent6490|1|False|606.85|17|Positive|y9++|10|5|2|492.29|380|1804128.0,Agilent6490|2|False|606.85|13|Positive|y10++|10|5|2|520.8|380|1595249.0,Agilent6490|3|False|606.85|17|Positive|y8|10|5|2|886.52|380|910886.0,Agilent6490|4|False|606.85|17|Positive|y10|10|5|2|1040.6|380|357409.0,Agilent6490|5|False|606.85|25|Positive|y2|10|5|2|248.16|380|307075.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'ATGPPVSELITK', 'Concentration Range': ['NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'Mean Conc.:2474.58 (fmol/\\xc2\\xb5g Lung)<br/>Mouse Lung', 'UniProtKB Accession': 'P43276', 'Assay Information': [{'GRAVY Score': '0.04', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1092.55', 'AAA Concentration': 'NA'}, {'GRAVY Score': '0.04', 'CZE Purity': '68.85', 'Special Residues': 'K+8', 'Molecular Weight': '1100.55', 'AAA Concentration': '9.520000'}], 'Gradients': ['NA', 'Gradient 2,column: Agilent Zorbax Eclipse Plus C18 RRHD  2.1 x 150mm  1.8um, Time [min] | B [%] | Flow [ml/min], 0|1.5|0.4, 1.5|6.3|0.4, 16|13.5|0.4, 18|13.77|0.4, 33|22.5|0.4, 38|40.5|0.4, 39|81|0.4, 42.9|81|0.4, 43|1.5|0.4'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|551.2875|13|Positive|y9|10|5|2|917.4454|380|62568.0,Agilent6490|2|True|551.2875|17|Positive|y7|10|5|2|775.3712|380|44865.0,Agilent6490|3|True|551.2875|17|Positive|b3|10|5|2|256.1656|380|32368.0,Agilent6490|4|True|551.2875|17|Positive|y8|10|5|2|846.4083|380|29259.0,Agilent6490|5|True|551.2875|9|Positive|y9++|10|5|2|459.2264|380|17130.0,Agilent6490|1|False|547.28|13|Positive|y9|10|5|2|909.43|380|62568.0,Agilent6490|2|False|547.28|17|Positive|y7|10|5|2|767.36|380|44865.0,Agilent6490|3|False|547.28|17|Positive|b3|10|5|2|256.17|380|32368.0,Agilent6490|4|False|547.28|17|Positive|y8|10|5|2|838.39|380|29259.0,Agilent6490|5|False|547.28|9|Positive|y9++|10|5|2|455.22|380|17130.0'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'ALAAGGYDVEK', 'Concentration Range': ['2474.58 (fmol/\\xc2\\xb5g Lung)|NA|NA|1|Mouse Lung|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1640.74 (fmol/\\xc2\\xb5g Heart)|NA|NA|1|Mouse Heart|Urea-based|Worthington Trypsin|6490|NA|NA|Female;1937.38 (fmol/\\xc2\\xb5g Brain)|NA|NA|1|Mouse Brain|Urea-based|Worthington Trypsin|6490|NA|NA|Female', 'NA']},{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'P43276', 'Assay Information': [{'GRAVY Score': '-0.31', 'CZE Purity': 'NA', 'Special Residues': 'K+8', 'Molecular Weight': '818.39', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['Instrument|Rank|Heavy|PrecursorIon|CollisionEnergy|Polarity|FragmentIon|Dwell|CellAcceleratorVoltage|ParentChargeState|ProductIon|Fragmentor|Abundance,Agilent6490|1|True|410.2085|9|Positive|y7|10|5|2|661.3395|380|122608.0,Agilent6490|2|True|410.2085|13|Positive|y5|10|5|2|533.2809|380|47730.0,Agilent6490|3|True|410.2085|17|Positive|y4|10|5|2|446.2489|380|24264.0,Agilent6490|4|True|410.2085|13|Positive|y6|10|5|2|604.3181|380|12936.0,Agilent6490|5|True|410.2085|9|Positive|y8++|10|5|2|381.6972|380|12208.0,Agilent6490|1|False|406.2014|9|Positive|y7|10|5|2|653.3395|380|122608.0,Agilent6490|2|False|406.2014|13|Positive|y5|10|5|2|525.2809|380|47730.0,Agilent6490|3|False|406.2014|17|Positive|y4|10|5|2|438.2489|380|24264.0,Agilent6490|4|False|406.2014|13|Positive|y6|10|5|2|596.3181|380|12936.0,Agilent6490|5|False|406.2014|9|Positive|y8++|10|5|2|377.6972|380|12208.0'], 'Unique in protein': 'NA', 'Peptide Sequence': 'GTGASGSFK', 'Concentration Range': ['NA']}", "SubCellular": "Nucleus|Chromosome", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "Histone H1.5", "UniProtKB Accession": "P43276"}, {"Human Gene": "YTHDC2", "Mouse Go Name": "N6-methyladenosine-containing RNA binding|response to tumor necrosis factor|germline cell cycle switching, mitotic to meiotic cell cycle|3'-5' RNA helicase activity|cytoplasm|spermatid development|RNA polymerase binding|ribonucleoprotein granule|positive regulation by host of viral genome replication|oocyte development|RNA-dependent ATPase activity|nucleus|endoplasmic reticulum|meiotic cell cycle|RNA binding|response to interleukin-1|ATP-dependent 3'-5' RNA helicase activity|ATP binding", "Human Disease Name": "NA", "Organism ID": "10090", "sel": "", "Peptide Sequence": "LASNALQEPSSFR", "Human UniProtKB Accession": "Q9H6S0", "Peptide Based Info": [{"Peptide in user's database": "NA", "Present in isoforms": "No", "Peptide unique in user's database": "NA", "Concentration View": "NA", "UniProtKB Accession": "B2RR83", "Assay Information": [{"GRAVY Score": "-0.38", "CZE Purity": "NA", "Special Residues": "NA", "Molecular Weight": "1418.72", "AAA Concentration": "NA"}], "Gradients": ["NA"], "Transitions": ["NA"], "Unique in protein": "Yes", "Peptide Sequence": "LASNALQEPSSFR", "Concentration Range": ["NA"]}], "Human ProteinName": "3'-5' RNA helicase YTHDC2", "Human Go Name": "N6-methyladenosine-containing RNA binding|ATP binding|response to tumor necrosis factor|germline cell cycle switching, mitotic to meiotic cell cycle|3'-5' RNA helicase activity|cytoplasm|spermatid development|RNA polymerase binding|ribonucleoprotein granule|positive regulation by host of viral genome replication|RNA-dependent ATPase activity|nucleus|endoplasmic reticulum|oocyte development|RNA binding|response to interleukin-1|meiotic cell cycle|ATP-dependent 3'-5' RNA helicase activity", "Human Drug Bank": "NA", "Biological Matrix": "NA", "Human Kegg Pathway Name": "NA", "Biological Matrix Details": [], "Gene": "Ythdc2", "Assay Info": "{\"Peptide in user's database\": 'NA', 'Present in isoforms': 'No', \"Peptide unique in user's database\": 'NA', 'Concentration View': 'NA', 'UniProtKB Accession': 'B2RR83', 'Assay Information': [{'GRAVY Score': '-0.38', 'CZE Purity': 'NA', 'Special Residues': 'NA', 'Molecular Weight': '1418.72', 'AAA Concentration': 'NA'}], 'Gradients': ['NA'], 'Transitions': ['NA'], 'Unique in protein': 'Yes', 'Peptide Sequence': 'LASNALQEPSSFR', 'Concentration Range': ['NA']}", "SubCellular": "Cytoplasm", "Knockout": "Mutant", "Strain": "Congenic strains", "Mouse Kegg Pathway Name": "NA", "Protein": "3'-5' RNA helicase YTHDC2", "UniProtKB Accession": "B2RR83"}]
}